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2, 3 
European Food Safety Authority (EFSA), Parma, Italy 
 
ABSTRACT 
The ANS Panel provides a scientific opinion re-evaluating the safety of Indigo Carmine (E132). The Panel 
observed  that Indigo Carmine was poorly absorbed and does not raise concern for genotoxicity. No adverse 
effects  in  subacute,  chronic,  reproduction  and  developmental  toxicity  studies,  and  no  modifications  of 
haematological and biological parameters in chronic toxicity studies have been identified at doses less than or 
equal to 500 mg/kg bw/day. The only report of an adverse effect was in testis with a LOAEL of 17 mg/kg 
bw/day  which  would  give  rise  to  a  safety  concern  if  confirmed.  The  Panel  considered  that  this  study  has 
shortcomings since it is not clear to the Panel whether the adverse effects observed were due to the food additive 
itself or to impurities and/or contaminants present in the material tested and/or to the conduct of the study. The 
Panel considered that the current ADI of 5 mg/kg bw/day for Indigo Carmine was applicable to a material with 
the same purity and manufacturing process as material used in studies without adverse effects on testis (93% 
pure colouring and 7% volatile matter) and concluded that any extension of this ADI to Indigo Carmine of lower 
purity and/or manufactured using a different process would require new data which would need to address the 
adverse effects on testis. The Panel noted that at the MPL, exposure estimates of Indigo Carmine would exceed 
the ADI for toddlers and children at the high level. Exposure estimates using the available usage and analytical 
data did not show an exceedance of the ADI for any population groups. 
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SUMMARY 
Following a request from the European Commission to the European Food Safety Authority (EFSA), 
the Panel on Food Additives and Nutrient Sources added to Food (ANS) was asked to deliver a 
scientific opinion re-evaluating the safety of Indigo Carmine (E 132) when used as a food additive. In 
this re-evaluation, only studies with Indigo Carmine and Indigotine were taken into consideration, 
provided that the identity of the test material was clear. However, only the term Indigo Carmine is 
used in this opinion.  
Joint FAO/WHO Expert Committee on Food Additives (JECFA) established a temporary Acceptable 
Daily Intake (ADI) of 0-2.5 mg/kg bw/day in 1969 that was increased to a full ADI of 0-5 mg/kg 
bw/day in 1975. These ADIs were probably based on the long-term rat study by Hansen et al. (1966) 
in which a significantly inhibited growth of male rats was observed at dietary doses of 1000 and 
2500 mg/kg bw/day. In this study, the no observed adverse effect level (NOAEL) was determined to 
be  equivalent  to  500 mg/kg  bw/day.  JEFCA  established  a  temporary  ADI  in  1969  probably  by 
applying an uncertainty factor of 200 to the above NOAEL. In 1975, JECFA applied an uncertainty 
factor of 100 to the NOAEL of 500 mg/kg bw/day to derive an ADI of 0-5 mg/kg bw/day for Indigo 
Carmine. In 1975, the EU Scientific Committee for Food (SCF) endorsed the ADI of 5 mg/kg bw/day 
as  established by  JECFA.  In  the  latest evaluation  of  1984, taking  into  consideration  more  recent 
studies, the SCF agreed to retain this ADI. JECFA and the SCF in their evaluations used the term of 
Indigotine to design Indigo Carmine.  
In vivo studies demonstrated that radioactivity from 
35S-Indigo Carmine was poorly detected in urine 
(1.6 to 2.1 % of the radioactivity) after oral administration in rats. Moreover, incubation of 
35S-Indigo 
Carmine with intestinal contents of rats for 48 hours suggested that isatin-5-sulphonic acid and 5-
sulphoanthranilic acid might be metabolites formed by intestinal bacteria. By comparison to the data 
obtained  after  intravenous  administration,  the  Panel  considered  that  the  data  available  on  the 
absorption, metabolism and excretion indicated that Indigo Carmine or its metabolites were poorly 
absorbed.  However,  the  Panel  noted  that  both  identification  of  faecal  metabolites  and  tissue 
distribution of radioactivity were not investigated in these studies. 
Overall the Panel considered that based on the available data including a newly performed in vivo 
study on micronuclei induction, Indigo Carmine does not raise concern for genotoxicity. 
In a subacute toxicity study (45-day) performed with adult male Swiss albino mice of B-6 strain (5 
animals/group) at oral doses of 0, 17 and 39 mg Indigo Carmine/kg bw/day, statistically significant 
severe adverse effects on the testis were characterised by Dixit and Goyal, 2013. The Panel noted that 
no NOAEL could be identified in this study and the lowest observed adverse effect level (LOAEL) 
was 17 mg/kg bw/day, the lowest dose level tested. The Panel noted limitations in the design of the 
study and lack of information on the specifications of the test material used in the study.  
Several chronic toxicity studies were available when JECFA allocated the ADI (1975). Two chronic 
and carcinogenicity studies, one in rats and one in mice, were published since the latest evaluation of 
Indigo Carmine by JECFA in 1975.  
In a long-term toxicity study in mice, microscopical evaluation of selected tissues revealed a variety of 
randomly  distributed  neoplastic,  degenerative,  hyperplastic  and  inflammatory  changes  usually 
encountered  in  ageing  mice  (Borzelleca  and  Hogan,  1985).  These  changes  occurred  without 
relationship  to  dose  and  were  considered  to  be  unrelated  to  the  dietary  administration  of  Indigo 
Carmine. It was, therefore, concluded that this lifetime exposure of mice to Indigo Carmine did not 
demonstrate  carcinogenic  or  toxic  effects.  The  Panel  agreed  with  the  authors  that  the  NOAEL 
identified in this study was 5 % in the diet providing an average intake of 8259 mg Indigo Carmine/kg 
bw/day for males and 9456 mg Indigo Carmine/kg bw/day for females.  Re-evaluation of Indigo Carmine (E 132) as a food additive  
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In  a  chronic/carcinogenicity  study,  a  statistically  significant  increased  incidence  of  gliomas  and 
malignant mammary glands tumours was seen in the male rats at the highest dose level of 1282 mg 
Indigo Carmine/kg bw/day. Overall, the Panel identified a NOAEL in this study of 632 mg/kg bw/day 
for male rats, the mid-dose, based on these carcinogenic effects. In the absence of any genotoxic 
activity,  the  Panel  considered  that  Indigo  carmine  was  acting  as  a  non-genotoxic  carcinogen  and 
therefore, that there would be a threshold for this effect. 
In a multigeneration reproductive toxicity study no test substance related effects were observed up to 
doses of 250 mg/kg bw/day. No adverse effects have been detected in developmental studies in rats 
and rabbits at tested doses (0, 25, 75 or 250 mg/kg bw/day). The Panel noted that the concentrations 
tested in the developmental toxicity studies were lower than the dose levels up to 2000 mg/kg bw/day 
used in several subacute or long-term toxicity studies but close to the NOAEL of 500 mg/kg bw/day 
on which JECFA and SCF based the ADI.  
No cases of Indigo Carmine intolerance or allergy have been reported after ingestion.  
Overall, the Panel noted that no adverse effects in subacute, chronic, reproduction and developmental 
toxicity studies, and no modifications of haematological and biological parameters in chronic toxicity 
studies have been identified at doses less than or equal to 500 mg/kg bw/day. The only report of an 
adverse effect was in testis with a LOAEL of 17 mg/kg bw/day which would give rise to a safety 
concern if confirmed. The Panel considered that this study has shortcomings since it is not clear to the 
Panel whether the adverse effects observed were due to the food additive itself or to impurities and/or 
contaminants present in the material tested and/or to the conduct of the study. However no effects on 
the testes or reproductive function were observed in chronic toxicity studies and in a 3-generation 
reproduction  toxicity  study  undertaken  with  Indigo  Carmine  (FD&C  Blue  No  2)  containing 
approximately 93% pure colouring and 7% volatile matter (Borzelleca et al., 1985, 1986; Borzelleca 
and Hogan 1985). The Panel noted that the material as described in the Dixit and Goyal study (2013) 
is presumed to meet the current EU specifications and it cannot be excluded that such material could 
be legally used as a food additive in the EU market.  
The Panel confirmed the ADI of 5 mg/kg bw/day for Indigo Carmine. The Panel considered that the 
current ADI was applicable to a material with a purity of 93% pure colouring and manufactured using 
processes resulting in comparable residuals as material used in the Borzelleca et al. studies (1985, 
1986) and Borzelleca and Hogan (1985). Given the uncertainties in the database, the Panel was not 
able to conclude whether this ADI should apply to Indigo Carmine with lower purity manufactured 
using these same processes or material manufactured using a different but not equivalent process.  
The  Panel  considered  that  any  extension  of  this  ADI  to  Indigo  Carmine  of  lower  purity  and/or 
manufactured using a different process would require new data which would need to address the 
adverse effects on testis observed in the Dixit and Goyal (2013) study. The chemical identity of the 
tested food additive, including the presence of possible impurities and/or contaminants, should be 
investigated and reported. The EFSA Guidance for submission for food additives evaluation (EFSA 
ANS Panel, 2012) requires information on the manufacturing process to identify hazards which may 
need to be controlled in the specifications.  
Furthermore, the Panel considered that the current specifications should be revised in order to restrict 
the Indigo Carmine (E 132) permitted as food additive to that for which the ADI is applicable. 
Exposure assessment for food additives under re-evaluation was carried out by the ANS Panel based 
on  (1) MPLs  set down in  the  EU legislation  (defined  as  the  regulatory  maximum  level  exposure 
assessment  scenario) and (2)  the  availability  of  adequate  usage  or  analytical data  (defined  as  the 
refined exposure assessment scenario). 
To date, the ANS Panel has used the maximum concentration value (maximum reported use level or 
maximum value from the analytical results) available for each authorised food category. However, Re-evaluation of Indigo Carmine (E 132) as a food additive  
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given the extensive range of analytical data that have been made available through the most recent 
calls, the ANS Panel considered that this should also be used in additional scenarios of the exposure 
assessment approach intended to provide more realistic exposure estimates.  
Overall, the Panel considered the regulatory maximum level exposure assessment scenario as being 
conservative since it assumes that all processed foods and beverages contain the food additive Indigo 
Carmine at the MPLs. The Panel considered that exposure assessment approach that uses reported use 
levels and analytical data was a more realistic scenario, since it was based on the extensive range of 
analytical data and assumes that the processed foods and beverages contain the additive at the mean 
concentration level for all products (non-brand-loyal consumer scenario) and considers one product 
containing Indigo Carmine at the maximum concentration level (brand-loyal consumer scenario). 
Using  the  regulatory  maximum  level  exposure  assessment  scenario,  exposure  estimates  of  Indigo 
Carmine (E 132) exceed the ADI for toddlers and children at the high level (95
th percentile). The main 
contributing  food  categories  to  the  total  mean  exposure  estimates  for  adolescents,  adults  and  the 
elderly  in  this  scenario  were  flavoured  drinks  and  fine  bakery  wares.  For  children,  the  main 
contributing food categories were flavoured drinks, fine bakery wares and flavoured fermented milk 
products, while for toddlers, the main contributing food categories were flavoured fermented milk 
products and fine bakery wares. 
For  the  refined  exposure  assessment  scenarios  (brand-loyal  and  non-brand-loyal),  none  of  the 
population groups exceeded the ADI of 5 mg/kg bw/day, neither at the mean nor at the high level (95
th 
percentile). However, the Panel noted that this scenario was calculated using limited data provided by 
industry. The Panel further noted that for the food categories where both usage levels and analytical 
results were available, the analytical results were much lower than the use levels reported by industry. 
The Panel noted that both reported use levels and quantified analytical results were reported only for 
the food categories of chewing gum, flavoured drinks and desserts. For several food products for 
which the use of Indigo Carmine is authorised e.g. flavoured fermented milk products, seasonings and 
condiments, mustard, soups and broths, sauces, cider and perry, aromatised wine based-products and 
other  alcoholic  drinks,  no  usage  data  nor  quantified  positive  analytical  results  were  reported.  In 
addition, the Panel further noted that for some other authorised food categories such as edible ices, 
fine bakery wares, fish roe, spirit drinks, potato-, cereal, flour-, or starch-based snacks and processed 
nuts, no usage data had been reported while positive analytical results were obtained from analytical 
data. 
The  Panel  concluded  that  at  the  maximum  permitted  level  of  use,  exposure  estimates  of  Indigo 
Carmine (E 132) would exceed the ADI for toddlers and children at the high level. Exposure estimates 
using  the  available  usage  and  analytical  data  did  not  show  an  exceedance  of  the  ADI  for  any 
population groups. 
The Panel noted that the three main contributing food categories for age-groups where MPL scenario 
estimates exceeded the ADI showed high number of analytical data far below MPL or had no use level 
reported combined with no detection in limited analytical data. The Panel therefore considered that it 
is not likely that the ADI will be exceeded. Re-evaluation of Indigo Carmine (E 132) as a food additive  
 
EFSA Journal 2014;12(7):3768  5 
TABLE OF CONTENTS 
Abstract .................................................................................................................................................... 1 
Summary .................................................................................................................................................. 2 
Table of contents ...................................................................................................................................... 5 
Background as provided by the European Commission  ........................................................................... 6 
Terms of reference as provided by the European Commission ................................................................ 6 
Assessment ............................................................................................................................................... 7 
1.  Introduction ..................................................................................................................................... 7 
2.  Technical data .................................................................................................................................. 7 
2.1.  Identity of the substance ......................................................................................................... 7 
2.2.  Specifications .......................................................................................................................... 8 
2.3.  Manufacturing process ............................................................................................................ 9 
2.4.  Methods of analysis in food .................................................................................................... 9 
2.5.  Reaction and fate in food ...................................................................................................... 10 
2.6.  Case of need and proposed uses  ............................................................................................ 10 
2.7.  Reported use levels or data on analytical levels of Indigo Carmine (E 132) in food  ............ 12 
2.7.1.  Summarised data on reported use levels in foods provided by industry........................... 12 
2.7.2.  Summarised data on concentration levels in foods from Member States ......................... 13 
2.8.  Information on existing authorisations and evaluations........................................................ 13 
2.9.  Exposure assessment  ............................................................................................................. 14 
2.9.1.  Food consumption data used for exposure assessment  ..................................................... 14 
2.9.2.  Exposure to Indigo Carmine (E 132) from its use as a food additive  ............................... 16 
2.9.3.  Main food categories contributing to exposure to Indigo Carmine (E 132) using the 
regulatory maximum level exposure assessment scenario............................................................. 18 
2.9.4.  Main food categories contributing to exposure to Indigo Carmine (E 132) using the 
refined exposure assessment scenarios .......................................................................................... 18 
2.9.5.  Uncertainty analysis ......................................................................................................... 21 
3.  Biological and toxicological data .................................................................................................. 21 
3.1.  Absorption, distribution, metabolism and excretion ............................................................. 21 
3.1.1.  In vitro .............................................................................................................................. 21 
3.1.2.  In vivo  ............................................................................................................................... 21 
3.2.  Toxicological data  ................................................................................................................. 23 
3.2.1.  Acute oral toxicity ............................................................................................................ 23 
3.2.2.  Short-term and subchronic toxicity .................................................................................. 23 
3.2.3.  Genotoxicity ..................................................................................................................... 24 
3.2.4.  Chronic toxicity and carcinogenicity ................................................................................ 27 
3.2.5.  Reproductive and developmental toxicity ........................................................................ 30 
3.2.6.  Hypersensitivity, allergenicity and intolerance ................................................................ 31 
4.  Discussion  ...................................................................................................................................... 31 
Conclusions ............................................................................................................................................ 35 
Documentation provided to EFSA ......................................................................................................... 36 
References .............................................................................................................................................. 36 
Appendices ............................................................................................................................................. 41 
Appendix A.  Summary of reported use levels (mg/kg) of Indigo Carmine (E 132) provided by 
industry  41 
Appendix B.  Summary of analytical results (mg/kg) of Indigo Carmine (E 132) provided by 
Members States  42 
Appendix C.  Concentration levels of Indigo Carmine (E 132) used in the refined exposure 
scenarios (mg/kg) ................................................................................................................................... 46 
Appendix D.  Summary of total estimated exposure of indigo carmine (E 132) from its use as a 
food additive for MPL scenario and refined exposure scenarios per population group and survey: mean 
and high level (mg/kg bw/day)  ............................................................................................................... 48 
Glossary and abbreviations .................................................................................................................... 50 Re-evaluation of Indigo Carmine (E 132) as a food additive  
 
EFSA Journal 2014;12(7):3768  6 
BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
Regulation (EC) No 1333/2008
4 of the European Parliament and of the Council on food additives 
requires that food additives are subject to a safety evaluation by the European Food Safety Authority 
(EFSA) before they are permitted for use in the European Union. In addition, it is foreseen that food 
additives must be kept under continuous observation and must be re-evaluated by EFSA.  
For this purpose, a programme for the re -evaluation of food additives that were already permitted in 
the European Union before 20 January 2009 has been set up under Regulation (EU) No 257/2010
5. 
This Regulation also foresees that food addi tives are re-evaluated whenever necessary in light of 
changing conditions of use and new scientific information. For efficiency and practical purposes, the 
re-evaluation should, as far as possible, be conducted by group of food additives according to the main 
functional class to which they belong. 
The order of priorities for the re-evaluation of the currently approved food additives should be set on 
the basis of the following criteria: the time since the last evaluation of a food additive by the Scientific 
Committee on Food (SCF) or by EFSA, the availability of new scientific evidence, the extent of use of 
a food additive in food and the human exposure to the food additive taking also into account the 
outcome of the Report from the Commission on Dietary Food Additive Intake in the EU
6 of 2001. The 
report  “Food  additives  in  Europe  2000
7” submitted by the Nordic Council of Ministers to the 
Commission, provides additional information for the prioritisation of additives for re-evaluation. As 
colours were among the first additives to be evaluated, these food additives should be re-evaluated 
with a highest priority. 
In 2003, the Commission already requested EFSA to start a systematic re-evaluation of authorised 
food additives. However, as a result of adoption of Regulation (EU) 257/2010 the 2003 Terms of 
References are replaced by those below. 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
The Commission asks the European Food Safety Authority to re-evaluate the safety of food additives 
already permitted in the Union before 2009 and to issue scientific opinions on these additives, taking 
especially into account the priorities, procedures and deadlines that are enshrined in the Regulation 
(EU) No 257/2010 of 25 March 2010 setting up a programme for the re-evaluation of approved food 
additives in accordance with the Regulation (EC) No 1333/2008 of the European Parliament and of the 
Council on food additives. 
                                                       
4  OJ L 354, 31.12.2008, p.16. 
5  OJ L 80, 26.03.2010, p. 19 
6  COM(2001) 542 final. 
7  Food Additives in Europe 2000, Status of safety assessments of food additives presently permitted in the EU, Nordic 
Council of Ministers, TemaNord 2002:560. Re-evaluation of Indigo Carmine (E 132) as a food additive  
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ASSESSMENT 
1.  Introduction 
The present opinion deals with the re-evaluation of the safety of Indigo Carmine/Indigotine (E 132) 
when used as a food additive. The Panel noted that the term Indigotin is sometimes used to indicate 
Indigo while Indigotine is a synonym of Indigo Carmine (Regulation (EC) No 1333/2008
8). In this re-
evaluation, only studies with Indigo Carmine and Indigotine were taken into consideration, provided 
that the identity of the test material was clear. However, only the term Indigo Carmine is used in this 
opinion. 
Indigo Carmine (E 132) is an indigoid colour authorised as a food additive in  the EU in accordance 
with Annex II to Regulation (EC) No  1333/2008 and has been  previously evaluated by the Joint 
FAO/WHO Expert Committee on Food Additives (JECFA) in 19 69 and 1975, and the EU Scientific 
Committee for Food (SCF) in 1975 and 1984.  
The Panel on Food Additives and Nutrient Sources added to Food (ANS) was not provided with a 
newly submitted dossier and based its evaluation on previous evaluations, additional literature that 
became available since then and the data available following an EFSA  public call for data.
9,10,11 The 
Panel noted that not all original studies on which previous evaluations were based were available to 
the Panel. 
2.  Technical data 
2.1.  Identity of the substance 
Indigo Carmine is an indigoid colouring substance. Its systematic name (IUPAC) is disodium (2E)-3-
oxo-2-(3-oxo-5-sulphonato-2,3-dihydro-1H-indol-2-ylidene)-2,3-dihydro-1H-indole-5-sulphonate,  the 
CAS Registry Number is 860-22-0, the EINECS number is 212-728-8, the Colour Index number is 
73015. The molecular formula is C16H8Na2N2O8S2 and the molecular weight is 466.36 g/mol. The 
structural formula is given in Figure 1. 
 
 
Figure 1:   Structural  formula  of  Indigo  Carmine  (disodium  3,3′-dioxo-2,2′-bi-indo-lylidene-5,5′-
disulphonate) 
Indigo Carmine takes the form of a dark-blue powder or granules, is soluble in water (1.6 % at 20 
0C 
in water (Sensiet Colours Group, 2011)) and sparingly soluble in ethanol (JECFA, 2010). 
                                                       
8    Regulation (EC) No 1333/2008 of the European Parliament and of the Council of 16 December 2008 on food additives.  
    OJ L 354, 31.12.2008. 
9    Call for scientific data on food colours to support re-evaluation of all food colours authorised under the EU legislation.  
    Published: 8 December 2006. Available online: http://www.efsa.europa.eu/en/dataclosed/call/afc061208.htm  
10   Call for scientific data on Indigo Carmine (E 132). Published: 26 June 2011. Available online:  
  http://www.efsa.europa.eu/en/data/call/ans110126.htm . 
11   Call for food additives usages level and/or concentration data in food and beverages intended to human consumption.  
Published: 27 March 2013. Available online: http://www.efsa.europa.eu/en/dataclosed/call/130327.htm Re-evaluation of Indigo Carmine (E 132) as a food additive  
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At least more than 100 synonyms are known (ChemIdplusAdvances, online); the most commonly used 
names are: CI natural blue II, FD&C Blue No. 2, Indigotine and Acid blue 74. 
2.2.  Specifications 
Specifications for Indigo Carmine (E 132) have been defined in Commission Regulation (EU) No 
231/2012
12 and by JECFA (JECFA, 2010) (Table 1).  
According to  Commission Regulation (EU) No 231/2012 , Indigo Carmine consists essentially of a 
mixture of disodium 3,3′-dioxo-2,2′-bi-indo-lylidene-5,5′-disulphonate and disodium 3,3′-dioxo-2,2′-
bi-indolylidene-5,7′-disulphonate  and  subsidiary  colouring  matters  together  with  sodium  chloride 
and/or sodium sulphate as the principal uncoloured components. Indigo Carmine is described as the 
sodium salt.  
The  purity  of  Indigo  Carmine  is  specified  as  to  be  not  less  than  85 %  total  colouring  matters, 
calculated  as  the  sodium  salt,  with  disodium  3,3‟-dioxo-2,2‟-bi-indolylidene-5,7‟-disulphonate  not 
more than 18 %. 
The remainder is   0.2 % water insoluble matter,   1.0 % subsidiary colouring matters (excluding 
disodium  3,3′-dioxo-2,2′-bi-indolylidene-5,7′-disulphonate),  a  total  of   0.5 %  organic  compounds 
other than colouring matters (e.g. of isatin-5-sulphonic acid or 5-sulphoanthranilic acid or anthranilic 
acid),   0.01 % unsulphonated primary aromatic amines (calculated as aniline) and   0.2 % of ether 
extractable matter under neutral conditions (Commission Regulation (EU) No 231/2012).  
The Panel noted that if the existing specifications were extended to include < 15 % of sodium chloride 
and/or  sodium  sulphate  as  the  principal  uncoloured  components,  most  of  the  material  would  be 
accounted for. 
Table 1:   Specifications  for  Indigo  Carmine  according  to  Commission  Regulation  (EU)  No 
231/2012 and JECFA (2010) 
Purity  Commission Regulation (EU) No 
231/2012  JECFA (2010) 
Assay 
≥ 85 % (calculated as sodium salt) 
≤ 18 % disodium 3,3‟-dioxo-2,2‟-
bi-indolylidene-5,7‟-disulphonate 
 85 % total colouring matters. 
 18 % of disodium 3,3' dioxo-
[delta-2,2‟-biindoline]-5,7'-
disulphonate 
Water insoluble matter  ≤ 0.2 %  ≤ 0.2 % 
Subsidiary colouring matters 
≤ 1.0 % (excluding disodium 3,3‟-
dioxo-2,2‟-bi-indolylidene-5,7‟-
disulphonate) 
≤ 1.0 % 
(except disodium 3,3'-dioxo-[delta-
2,2‟-biindoline]- 5,7'-disulphonate) 
Organic  compounds  other  than 
colouring matters 
- Isatin-5-sulphonic acid 
- 5-sulphoanthranilic acid 
- Anthranilic acid 
 
 
 
≤ 0.5 % 
 
 
 
≤ 0.5 % 
Unsulphonated  primary  aromatic 
amines  ≤ 0.01 % (calculated as aniline)  ≤ 0.01 % (calculated as aniline) 
Ether extractable matter  ≤ 0.2 % (under neutral conditions)  ≤ 0.2 % 
Arsenic  ≤ 3 mg/kg  - 
Lead  ≤ 2 mg/kg  ≤ 2 mg/kg 
Mercury  ≤ 1 mg/kg  - 
Cadmium  ≤ 1 mg/kg  - 
                                                       
12 Commission  Regulation  (EU)  No  231/2012  of  9  March  2012  laying  down  specifications for  food  additives listed  in 
Annexes II and III to Regulation (EC) No 1333/2008 of the European Parliament and of the Council. OJ L 83, 22.3.2012. Re-evaluation of Indigo Carmine (E 132) as a food additive  
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The Panel noted that the specifications for the purity of Indigo Carmine would permit concentrations 
of unsulphonated aromatic amines to be present in concentrations of up to 100 mg/kg Indigo Carmine 
(calculated as aniline). Given the maximum allowed concentration of Indigo Carmine that can be 
added  to  food  (500 mg/kg  food),  the  concentration  of  these  unidentified  unsulphonated  primary 
aromatic amines in food could be up to 50 μg/kg food.  
According to Commission Regulation (EU) No 231/2012, the above purity criteria also apply to the 
raw material from which the aluminium lake is produced. In addition, under neutral conditions, the 
aluminium lake should contain   0.5 % HCl-insoluble material and   0.2 % ether-extractable material. 
There are no additional specification requirements for the aluminium lake.  
The  Panel  noted  that  the  aluminium  lake  of  the  food  additive  could  add  to  the  daily  intake  of 
aluminium for which a Tolerable Weekly Intake (TWI) of 1 mg aluminium/kg bw/week has been 
established (EFSA, 2008) and that therefore specifications for the maximum level of aluminium in the 
lakes may be required. 
2.3.  Manufacturing process 
Indigo Carmine is prepared by the sulphonation of Indigo (2,2'-bindoline-3,3'-dione; CAS No: 482-89-
3) that is one of the earliest known naturally occurring dyes. Originally, it was obtained from the 
leaves of plants  Indigofera tinctoria, Indigofera suifruticosa or Isatis tinctoria where it occurs as 
indican, a glycoside of indoxyl. An enzyme known as indimulsin is added to hydrolyze the indican 
into indoxyl and glucose. Oxidation by exposure to air converts indoxyl to indigo (Steingruber, 2004). 
At the beginning of the 20
th century the production by chemical synthesis superseded the extraction 
from plants. Reactants such as N-phenylglycine or N-(2-carboxyphenyl)glycine are heated with alkali 
under controlled conditions to produce indoxyl which is subsequently oxidized in air to form Indigo 
(Steingruber, 2004).  
According to US Code of Federal Regulations (CFR, 1983) and information provided by industry 
(Sensiet  Colours  Group,  2011),  the indigo  (or  indigo  paste)  is  manufactured by  the  fusion  of  N-
phenylglycine (prepared from aniline and formaldehyde) in a molten mixture of sodamide and sodium 
and  potassium  hydroxides  under  ammonia  pressure.  The  indigo  is  isolated  and  subjected  to 
purification procedures. Indigo Carmine is obtained by sulphonation of indigo. This is accomplished 
by heating indigo (or indigo paste) in the presence of sulphuric acid. The dye is isolated and subjected 
to purification procedures. 
Indigo Carmine may be converted to the corresponding aluminium lake under aqueous conditions by 
reacting aluminium oxide with the colouring matter. Aluminium oxide is usually freshly prepared by 
reacting aluminium sulphate or aluminium chloride with sodium carbonate or sodium bicarbonate or 
aqueous ammonia. Following lake formation, the product is filtered, washed with water and dried 
(JECFA, 2004). 
2.4.  Methods of analysis in food 
Various analytical methods for the determination of synthetic food colours have been reported in the 
literature.  Thin  layer  chromatography  (TLC)  permits  a  qualitative  analysis  (IRMM,  2013). 
International  Standard  ISO  13469
13  is a TLC meth od for the detection of 12 synthetic colours  
including Indigo Carmine in meat and meat products. Methods for the determination of Indigo 
Carmine together with other synthetic colours in alcoholic beverages (Prado et al., 2006) or milk 
beverage (Huang et al., 2002) have been developed using capillary electrophoresis.  Other methods 
proposed for the analysis of Indigo Carmine and other synthetic colours in commercial products are 
based  on  high-performance liquid chromatography   (HPLC) combined with multivariate   analysis 
(Chen et al., 1998; Berzas et al., 1999, Nevado et al., 1999; Kiseleva et al., 2003; Minioti et al., 2007; 
Yoshioka and Ichihashi, 2008; Mahnaz et al., 2012; Suh and Choi, 2012) and in the recent years more 
                                                       
13   Available online: https://www.iso.org/obp/ui/#iso:std:iso:13496:ed-1:v1:en  Re-evaluation of Indigo Carmine (E 132) as a food additive  
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sophisticated analytical techniques combining liquid chromatography with mass spectroscopy have 
been  reported  (Chao  et  al.,  2011;  Feng  et  al.,  2011).  Recently,  a  method  based  on  liquid 
chromatography (LC) with photodiode array (PDA) detection have been used for the determination of 
seven food colours including Indigo Carmine in a small survey of 44 food products (Harp et al., 2013). 
2.5.  Reaction and fate in food 
An aqueous 0.1 % solution of radiochemically pure 
35S-labelled Indigo Carmine was allowed to stand 
at room temperature for periods ranging from one day to six months. After one week 5 % of the 
radioactivity was identified as isatin-5-sulphonic acid. After six months 50 % of the radioactivity was 
present as the parent compound, 12 % was isatin-5-sulphonic acid and 38 % was 5-sulphoanthranilic 
acid (Lethco and Webb, 1966). 
In general, the majority of colour additives are unstable in combination with oxidising and reducing 
agents in food. Since colour depends on the existence of a conjugated unsaturated system within the 
dye molecule, any substance which modifies this system (e.g. oxidising or reducing agents, sugars, 
acids, and salts) will affect the colour (Scotter and Castle, 2004). 
According to industry (Sensiet Colours Group, 2011), the conjugated unsaturated system which forms 
part of the structure of Indigo Carmine is responsible for the dye colour; any substance which interacts 
or alters this unit of the molecule will affect the colour. As a result, Indigo Carmine will generally be 
unstable in the presence of oxidising or reducing agents, sugars, acids, salts etc. The recommended 
shelf-life of Indigo Carmine by industry is 4 to 6 years, depending on the manufacturer, stored in its 
original container in a dry, cool and well ventilated place (Sensiet Colours Group, 2011). 
2.6.  Case of need and proposed uses 
Maximum permitted levels (MPLs) of Indigo Carmine (E 132) have been defined in Annex II to 
Regulation (EC) No 1333/2008 on food additives. 
Currently, Indigo Carmine (E 132) is an authorised food colour in the EU with MPLs ranging from 50 
to 500 mg/kg in foods. Indigo Carmine is included in Group III of food colours with a combined 
maximum limit. 
Table 2 summarises foods that are permitted to contain Indigo Carmine (E 132) and the corresponding 
MPLs as set by Annex II to Regulation (EC) No 1333/2008. 
Table 2:   MPLs of Indigo Carmine (E 132) in foods according to the Annex II to Regulation (EC) 
No 1333/2008 
FCS
(a) 
Category 
number 
Food category  Restrictions/exceptions 
MPL 
(mg/L or 
mg/kg as 
appropriate) 
01.4  Flavoured fermented milk products 
including heat-treated products    150 
01.6.3  Other creams  only flavoured creams  150 
01.7.1  Unripened cheese excluding 
products falling in category 16  only flavoured unripened cheese  150 
01.7.3  Edible cheese rind    quantum satis 
01.7.6  Cheese products (excluding 
products falling in category 16)  only flavoured unripened products  100 
03  Edible ices    150 
04.2.4.1  Fruit and vegetable preparations 
excluding compote  only mostarda di frutta  200 
05.2  Other confectionery including 
breath freshening microsweets  except candied fruit and vegetables  300 Re-evaluation of Indigo Carmine (E 132) as a food additive  
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FCS
(a) 
Category 
number 
Food category  Restrictions/exceptions 
MPL 
(mg/L or 
mg/kg as 
appropriate) 
05.2  Other confectionery including 
breath freshening microsweets  only candied fruit and vegetables  200 
05.3  Chewing gum    300 
05.4 
Decorations, coatings and fillings, 
except fruit-based fillings covered 
by category 04.2.4 
only decorations, coatings and sauces, 
except fillings  500 
05.4 
Decorations, coatings and fillings, 
except fruit-based fillings covered 
by category 04.2.4 
only fillings  300 
06.6  Batters  only batters for coating  500 
07.2  Fine bakery wares    200 
08.2.3  Casings and coatings and 
decorations for meat 
only decorations and coatings except 
edible external coating of pasturmas  500 
08.2.3  Casings and coatings and 
decorations for meat  only edible casings  quantum satis 
09.2  Processed fish and fishery products 
including molluscs and crustaceans 
only surimi and similar products and 
salmon substitutes  500 
09.3  Fish roe  except Sturgeons´ eggs (Caviar)  300 
12.2.2  Seasonings and condiments  Only seasonings, for example curry 
powder, tandoori  500 
12.4  Mustard    300 
12.5  Soups and broths    50 
12.6  Sauces 
including pickles, relishes, chutney 
and piccalilli; excluding tomato-based 
sauces 
500 
12.9  Protein products, excluding 
products covered in category 01.8 
only meat and fish analogues based on 
vegetable proteins  100 
13.2 
Dietary foods for special medical 
purposes defined in Directive 
1999/21/EC (excluding products 
from food category 13.1.5) 
  50 
13.3 
Dietary foods for weight control 
diets intended to replace total daily 
food intake or an individual meal 
(the whole or part of the total daily 
diet) 
  50 
14.1.4  Flavoured drinks  excluding chocolate milk and malt 
products  100 
14.2.3  Cider and perry  excluding cidre bouché  200 
14.2.4  Fruit wine and made wine  excluding wino owocowe markowe  200 
14.2.6  Spirit drinks as defined in 
Regulation (EC) No 110/2008 
except: spirit drinks as defined in 
Article 5(1) and sales denominations 
listed in Annex II, paragraphs 1-14 of 
Regulation (EC) No 110/2008 and 
spirits (preceded by the name of the 
fruit) obtained by maceration and 
distillation, Geist (with the name of 
the fruit or the raw material used), 
London Gin, Sambuca, Maraschino, 
Marrasquino or Maraskino and Mistrà 
200 
14.2.7.1  Aromatised wines  except americano, bitter vino  200 
14.2.7.2  Aromatised wine-based drinks  except bitter soda, sangria, claria, 
zurra  200 
14.2.7.3  Aromatised wine-product cocktails    200 
14.2.8  Other alcoholic drinks including  only alcoholic drinks with less than  200 Re-evaluation of Indigo Carmine (E 132) as a food additive  
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FCS
(a) 
Category 
number 
Food category  Restrictions/exceptions 
MPL 
(mg/L or 
mg/kg as 
appropriate) 
mixtures of alcoholic drinks with 
non-alcoholic drinks and spirits with 
less than 15 % of alcohol 
15% of alcohol and nalewka na winie 
owocowym, aromatyzowana nalewka 
na winie owocowym, nalewka na winie 
z soku winogronowego, 
aromatyzowana nalewka na winie z 
soku winogronowego, napój winny 
owocowy lub miodowy, 
aromatyzowany napój winny owocowy 
lub miodowy, wino owocowe 
niskoalkoholowe and aromatyzowane 
wino owocowe niskoalkoholowe 
15.1  Potato-, cereal-, flour- or starch-
based snacks 
excluding extruded or expanded 
savoury snack products  100 
15.1  Potato-, cereal-, flour- or starch-
based snacks 
only extruded or expanded savoury 
snack products  200 
15.2  Processed nuts  only savoury-coated nuts  100 
16  Desserts excluding products covered 
in categories 01, 03 and 04    150 
17.1 
Food supplements supplied in a 
solid form including capsules and 
tablets and similar forms, excluding 
chewable forms 
  300 
17.2  Food supplements supplied in a 
liquid form    100 
17.3  Food supplements supplied in a 
syrup-type or chewable form  only solid food supplements  300 
17.3  Food supplements supplied in a 
syrup-type or chewable form  only liquid food supplements  100 
(a) FCS : Food Categorisation System (food nomenclature) presented in the Annex II to Regulation (EC) No 1333/2008. 
 
2.7.  Reported use levels or data on analytical levels of Indigo Carmine (E 132) in food 
Most food additives in the EU are authorised at a specific MPL. However, a food additive may be used 
at a lower level than the MPL. Therefore information on actual use levels is required for performing a 
more realistic exposure assessment, especially for those food additives for which no MPL is set and 
which are authorised according to quantum satis (QS).  
In the framework of Regulation (EC) No 1333/2008 on food additives and of Commission Regulation 
(EU) No 257/2010
14 regarding the re-evaluation of approved food additives,  EFSA issued a public 
call
15 for concentration data (usage and/or analytical data) on Indigo Carmine (E 132). 
In response to this public call, updated information on the actual use levels of Indigo Carmine (E 132) 
in foods was made available to EFSA by industry and Member States. 
2.7.1.  Summarised data on reported use levels in foods provided by industry 
Industry provided EFSA with data on use levels (n = 7) of Indigo Carmine (E 132) in foods for five 
out of the 35 food categories in which Indigo Carmine is authorised. 
                                                       
14 Commission Regulation (EU) No 257/2010 of 25 March 2010 setting up a programme for the re-evaluation of approved 
food additives in accordance with Regulation (EC) No 1333/2008 of the European Parliament and of the Council on food 
additives. OJ L 80, 26.3.2010, p. 19. 
15 Call for food additives usage level and/or concentration data in food and beverages intended for human consumption. 
Published: 27 March 2013. Available online: http://www.efsa.europa.eu/en/data/call/130327.htm Re-evaluation of Indigo Carmine (E 132) as a food additive  
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Updated information on the actual use levels of Indigo Carmine in foods was made available to EFSA 
by FoodDrinkEurope (FDE), the International Chewing Gum Association (ICGA), the Association of 
the European Self-Medication Industry (AESGP) and Capsugel for the following food categories of 
finished products: chewing gum (FCS Category 05.3), decorations, coatings of confectionary (FCS 
Category 05.4), non-alcoholic beverages (FCS Category 14.1.4), desserts (FCS Category 16) and food 
supplements (FCS Category 17). 
Appendix  A  provides data  on  the  use levels  of  Indigo  Carmine  (E  132) in foods  as  reported  by 
industry. 
2.7.2.  Summarised data on concentration levels in foods from Member States 
Additionally,  analytical  results  from  Member  States  were  collected  through  the  EFSA  call  for 
concentration data. The Panel noted that complete information on the methods of analysis was not 
made available to EFSA. In total, 4634 analytical results were reported to EFSA by 6 countries: 
Germany  (n = 2843),  Austria  (n = 994),  Czech  Republic  (n = 316),  Slovakia  (n = 289),  Hungary 
(n = 155) and Ireland (n = 37). The data were mainly on flavoured drinks (FCS Category 14.1.4), fine 
bakery wares (FCS Category 07.2) and other confectionary
16 including breath freshening microsweets 
(FCS Category 05.1). Foods were sampled between 2002 and 2013 and analysed the same year of 
collection. Out of this dataset, analytical results of Indigo Carmine were not quantified (< LOQ) in 740 
samples, not detected (< LOD) in 2926 samples, 247 were numerical values (quantified) and 721 were 
expressed  as  qualitative  results.  Only  22  of  these  samples  are  coming  from  a  non -accredited 
laboratory. 
Data resulting from  non-authorised uses
17  (n  =  593, in fruit  and vegetables  (FCS  04)  other than 
mostarda di frutta, cocoa and chocolate products (FCS 05.1), cereal and cereal products (FCS 06) 
other than batters, non-alcoholic beverages (FCS 14.1) others than flavoured drinks) and above the 
MPL set for authorised uses of Indigo Carmine (E 132) (one sample of confectionary (FCS 05.2) 
above the MPL of 300 mg/kg allocated for this food group) were not considered in the exposure 
assessment. The 721 samples expressed as qualitative results could also not be used in the exposure 
assessment as they only give binary results (i.e. indication of presence or absence of the food additive 
in the food analysed).  
Overall,  3319  out  of the 4634  total  analytical  results  reported for  Indigo  Carmine  in  foods  were 
included by Panel for use in the exposure estimates after discarding: the provided analytical results on 
foods in which Indigo Carmine is not authorised; a sample exceeding the MPL of authorised use; and 
values expressed as qualitative results. 
Appendix B shows the analytical results of Indigo Carmine (E 132) in foods as reported by Member 
States (whole set of analytical data reported and positive samples only). 
2.8.  Information on existing authorisations and evaluations 
Indigo Carmine (E 132) is authorised as a food additive in the EU in accordance with Annex II to 
Regulation (EC) No 1333/2008 on food additives. Specific purity criteria on Indigo Carmine (E 132) 
have been defined in the Commission Regulation (EU) No 231/2012. The calcium and the potassium 
salts are also permitted. 
JECFA established a temporary Acceptable Daily Intake (tADI) of 0-2.5 mg/kg bw/day in 1969 that 
was increased to a full ADI of 0-5 mg/kg bw/day in 1975.  
                                                       
16  Confectionary (FCS category 05) except cocoa and chocolate products (FCS category 05.1), chewing gum (FCS category 
05.3) and decorations, coatings and fillings (FCS category 05.4). 
17  Such result might be due to the use of multi -screen methods covering a large range of compounds from food control 
laboratories analysing the food samples and/or due to errors in the classification of the foods sampled. Re-evaluation of Indigo Carmine (E 132) as a food additive  
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In 1975 the SCF established an ADI of 5 mg/kg bw/day. In its latest evaluation in 1984, the SCF 
agreed to retain this ADI after taking into consideration more recent studies.  
JECFA and the SCF in their evaluations used the term Indigotine in place of Indigo Carmine. 
Indigo Carmine has also been reviewed by TemaNord (2002). 
2.9.  Exposure assessment 
2.9.1.  Food consumption data used for exposure assessment 
2.9.1.1.  EFSA Comprehensive European Food Consumption Database 
Since  2010,  the  EFSA  Comprehensive  European  Food  Consumption  Database  (Comprehensive 
Database) has been populated with data from national information on food consumption at a detailed 
level. Competent authorities in the European countries provide EFSA with data on the level of food 
consumption by the individual consumer from the most recent national dietary survey in their country 
(cf. Guidance of EFSA „Use of the EFSA Comprehensive European Food Consumption Database in 
Exposure Assessment‟ (EFSA, 2011a). 
The food consumption data gathered at EFSA were collected by different methodologies and thus 
direct  country-to-country comparisons  should  be  interpreted  with  caution.  Depending  on  the food 
category and the level of detail used for exposure calculations uncertainties could be introduced due to 
possible subjects‟ underreporting and/or misreporting of the consumption amounts.  
The  Panel  estimated  chronic  exposure  for  the  following  population  groups:  toddlers,  children, 
adolescents, adults and the elderly. Calculations were performed using individual body weights. For 
calculation of chronic exposure, intake statistics have been calculated based on individual average 
consumption over the total survey period excluding surveys with only one day per subject considered 
as not adequate to assess chronic dietary exposure. High percentile exposure was only calculated for 
those foods and population groups where the sample size was sufficiently large to allow calculation of 
the 95
th percentile of exposure (EFSA, 2011a). Therefore, in the present assessment, high levels of 
exposure for toddlers from Belgium, Italy and Spain were not included.  
Thus, for the present assessment, food consumption data were available from 26 different dietary 
surveys carried out in 17 European countries, as mentioned in Table 3:  
Table 3:   Population groups considered for the exposure estimates of Indigo Carmine (E 132) 
Population  Age range  Countries with food consumption surveys 
covering more than one day 
Toddlers  from 12 up to and including 
35 months of age 
Belgium,  Bulgaria,  Finland,  Germany,  Italy,  the 
Netherlands, Spain 
Children
18  from 36 months up to and 
including 9 years of age 
Belgium,  Bulgaria,  Czech  Republic,  Denmark, 
Finland,  France,  Germany,  Greece,  Italy,  Latvia, 
Netherlands, Spain, Sweden  
Adolescents  from 10 up to and including 
17 years of age 
Belgium, Cyprus, Czech Republic, Denmark, France, 
Germany, Italy, Latvia, Spain, Sweden 
Adults  from 18 up to and including 
64 years of age 
Belgium,  Czech  Republic,  Denmark,  Finland, 
France,  Germany,  Hungary,  Ireland,  Italy,  Latvia, 
Netherlands, Spain, Sweden, UK  
The elderly
18   from 65 years of age and 
older 
Belgium,  Denmark,  Finland,  France,  Germany, 
Hungary, Italy 
                                                       
18  The terms “children” and “the elderly” correspond respectively to “other children” and the merge of “elderly” and “very  
    elderly” in the Guidance of EFSA on the „Use of the EFSA Comprehensive European Food Consumption Database in  
    Exposure Assessment‟ (EFSA, 2011a). Re-evaluation of Indigo Carmine (E 132) as a food additive  
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Consumption records were codified according to the FoodEx classification system (EFSA, 2011b). 
Nomenclature  from  the  FoodEx  classification  system  has  been  linked  to  the  Food  Classification 
System (FCS) as presented in the Annex II to Regulation (EC) No 1333/2008, part D, to perform 
exposure estimates. In practice, FoodEx food codes were matched to the FCS food categories and the 
exposure was calculated by multiplying MPLs and values reported in Appendix C for each food group 
with their respective consumption amount per kg bw separately for each individual in the database, 
calculating the sum of exposure for each survey day for the individual and then deriving the daily 
mean for the survey period. Based on the individual exposures, the mean and 95
th percentile exposure 
was calculated for the total survey population separately for each survey and for the five population 
groups described in Table 3. 
2.9.1.2.  Food categories selected for the exposure assessment of Indigo Carmine 
The food categories in which the use of indigo carmine (E 132) is authorised were selected from the 
nomenclature of the EFSA Comprehensive Database (FoodEx classification system food codes), at a 
detailed level (up to FoodEx Level 4) (EFSA, 2011b).  
Some food categories are not referenced in the EFSA Comprehensive Database and therefore could 
not be taken into account in the present estimate. This  might result in an underestimation of the 
exposure. The food categories which were not taken into account are described below (in ascending 
order of the FCS codes): 
-  01.7.3. Edible cheese rind 
-  01.7.6. Cheese products (excluding products falling in category 16), only flavoured unripened 
products 
-  04.2.4.1. Fruit and vegetable preparations excluding compote, only mostarda di frutta  
-  05.4. Decorations, coatings and fillings, except fruit-based fillings covered by category 04.2.4, 
only decorations, coatings and sauces, except fillings and only fillings  
-  06.6. Batters  
-  08.2.3. Casings and coatings and decorations for meat 
-  14.2.4. Fruit wine and made wine 
For the following food categories, the restrictions which apply to the use of Indigo Carmine could not 
be  taken  into  account,  and  therefore  the  whole  food  category  was  considered  for  the  exposure 
estimates. This results in an overestimation of the exposure: 
-  01.7.1 Unripened cheese excluding products falling in category 16, only flavoured unripened 
products 
-  09.3. Fish roe, except Sturgeons' eggs (Caviar) 
-  14.2.3. Cider and perry, excluding cidre bouché  
-  14.2.7.1. Aromatised wines, except americano, bitter vino 
-  14.2.7.2. Aromatised wine-based drinks, except bitter soda, sangria, claria, zurra  
-  15.1. Potato-, cereal-, flour-, starch-based snacks, excluding extruded or expanded savoury 
snack products or only extruded or expanded savoury snack products Re-evaluation of Indigo Carmine (E 132) as a food additive  
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-  17.1/17.2/17.3. Food supplements, in solid or liquid form.  
The food category 01.6.3 (other creams
19 - only flavoured creams) cannot be not distinguished from 
the food category 01.6 (Cream and cream powder); the same applies in differentiating flavoured cream 
from plain cream. Therefore, taking into account t hat the whole food group  01.6 (Cream and cream 
powder) would result in a large overestimate, this food category ( 01.6.3) was not considered in the 
present estimate. 
Overall, 8 food categories were not taken into account  in the exposure assessment  because are not 
referenced in the EFSA Comprehensive Database and 7 food categories were included in the exposure 
assessment without considering the restrictions as set in Annex II to Regulation No 1333/2008. 
2.9.2.  Exposure to Indigo Carmine (E 132) from its use as a food additive 
Exposure assessment for food additives under re-evaluation is carried out by the ANS Panel based on: 
(1)  MPLs  set  down  in  the  EU  legislation  (defined  as  the  regulatory  maximum  level  exposure 
assessment scenario); and (2) the availability of adequate use levels or analytical data (defined as the 
refined exposure assessment scenario). 
2.9.2.1.  Regulatory maximum level exposure assessment scenario 
The regulatory maximum level exposure assessment scenario is based on the MPLs as set in Annex II 
to Regulation No 1333/2008 and listed in Table 2. 
The exposure estimates derived following this scenario should be considered as the most conservative 
since it assumes that the consumer will be continuously (over a lifetime) exposed to Indigo Carmine 
present in the food at the MPLs. 
2.9.2.2.   Refined exposure assessment scenario 
The refined exposure assessment scenario is based on information on reported use levels by industry 
and analytical results submitted to EFSA by Member States. This exposure scenario can only consider 
food categories where the above data were available to the Panel.  
Appendix C summarises the concentration levels of Indigo Carmine used in the refined  exposure 
assessment  scenario.  Based  on the  available  dataset,  the  Panel  calculated two  estimates  based  on 
different model populations:  
(1) The brand-loyal consumer scenario: It was assumed that a consumer is exposed long-term to 
the food additive present at the maximum reported use/analytical levels for one food category. 
This exposure estimate is calculated as follows:  
  Combining food consumption with the maximum of the maximum reported use levels 
or the maximum of the analytical results for the main contributing food category at the 
individual level. 
  Using the mean of the typical reported use levels or the mean of analytical results for 
the remaining food categories. 
(2) The non-brand-loyal consumer scenario: It was assumed that the population is exposed long-
term to the food additive present at the mean reported use/analytical levels in food. This 
exposure estimate is calculated using the mean of the typical reported use levels or the mean 
of analytical results for all food categories.  
                                                       
19  Within the FCS category 01.6 cream and cream powder, „other creams‟ are creams other than unflavoured pasteurised 
creams (FCS category 01.6.1) and unflavoured live fermented cream products and substitute products with a fat content of 
less than 20 % (FCS category 01.6.2). Re-evaluation of Indigo Carmine (E 132) as a food additive  
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In the refined exposure assessment scenarios, the concentration levels considered by the Panel were 
extracted  from  the  whole  dataset  received  (i.e.  reported  use  levels  and  analytical  results).  For 
analytical results, for each food category the mean medium-bound (<LOD/LOQ = ½ LOD/LOQ) is 
used, which takes into consideration left censored data (i.e. analytical results < LOD or < LOQ). For 
the reported use levels, the mean typical reported use level for each food category is used. 
If both reported use levels and analytical results were available for the same food category, the most 
reliable value was used.  
Food categories for which none or inadequate reported use/analytical levels were available were not 
considered in the exposure assessment. This concerns the following food categories:  
-  Processed fish and fishery products, only surimi and similar products and salmon substitutes 
(FCS 09.2),  
-  Protein products, only meat and fish analogues based on vegetables proteins (FCS 12.9) 
-  Dietary foods for special medical purposes (FCS 13.2) 
-  Dietary foods for weight control diets (FCS 13.3) 
The  Panel  noted  that  if  Indigo  Carmine  is  nevertheless  used  in  those  food  categories  for  which 
reported use/analytical levels were not available, the calculated refined exposure assessment might 
result in underestimation of exposure to Indigo Carmine. 
2.9.2.3.  Anticipated exposure to Indigo Carmine (E 132) 
Table 4 summarises the estimated exposure to Indigo Carmine (E 132) from its use as a food additive 
of all five population groups (Table 3). Detailed results by population group and survey are presented 
in Appendix D. 
Table 4:   Summary  of  anticipated  exposure  to  Indigo  Carmine  (E  132)  from  its  use  as  a  food 
additive using the regulatory maximum level exposure assessment scenario and refined 
exposure  scenarios,  in  five  population  groups  (min-max  across  the  dietary  surveys  in 
mg/kg bw/day)  
  Toddlers  Children  Adolescents  Adults  The elderly  
  (12-35 months)  (3-9 years)  (10-17 years)  (18-64 years)  (>65 years) 
Regulatory maximum level 
exposure assessment 
scenario 
         
  Mean  
  High level
20 
0.9-3.8 
2.8-7.1 
0.8-3.2 
1.8-6.7 
0.3-1.5 
1.0-3.2 
0.3-1.0 
0.7-2.3 
0.1-0.6 
0.5-1.4 
Refined estimated exposure 
scenario 
         
Brand-loyal scenario           
  Mean 
  High level
20 
0.1-0.4 
0.3-0.8 
0.1-0.3 
0.2-0.8 
0.04-0.2 
0.1-0.5 
0.02-0.1 
0.1-0.3 
0.02-0.1 
0.1-0.2 
Non-brand-loyal scenario           
  Mean 
  High level
20 
0.02-0.2 
0.1-0.3 
0.02-0.1 
0.1-0.3 
0.01-0.1 
0.03-0.1 
0.01-0.04 
0.02-0.1 
0.003-0.03 
0.01-0.1 
 
                                                       
20   typically 95
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2.9.3.  Main food categories contributing to exposure to Indigo Carmine (E 132) using the 
regulatory maximum level exposure assessment scenario  
Table 5:   Main food categories contributing to exposure to Indigo Carmine (E 132) using MPLs 
(> 5 % to the total mean exposure) and number of surveys in which each food category is 
contributing 
FCS 
Category 
number 
Foods 
Toddlers  Children  Adolescents  Adults  The 
elderly 
Range of % contribution to the total exposure  
(Number of surveys)
(a) 
01.4  Flavoured fermented milk 
products 
6.6-75.8  
(7) 
7.8 – 37.7  
(13) 
6.2 – 14.9 
(9) 
5.4 – 34.5 
(12) 
6.8 – 34.1 
(6) 
01.7.1 
Unripened cheese excluding 
products falling in 
category 16 
5.1-9.2  
(4) 
5.8-18.8 
(3) 
22.4  
(1) 
5.3-29.8  
(6) 
5.7-29.1  
(5) 
03  Edible ices  5.0-15.7  
(6) 
5.8-13.3 
(9) 
5.6-13.0  
(4) 
7.7-9.1  
(3) 
5.3-7.4  
(2) 
05.2 
Other confectionery including 
breath freshening 
microsweets   
5.2-10.7 
(5) 
7.5-10.2  
(2) 
9.2-9.8  
(2) 
5.9-6.4  
(2) 
07.2.  Fine bakery wares  11.5 – 55.2 
(6) 
12.4 – 48.7 
(13) 
13.9 – 46.2 
(11) 
5.7 - 45.2  
(14) 
11.8-38.9 
(6) 
12.5  Soups and broths  6.6  
(1) 
5.2 – 15.1 
(3) 
13.7  
(1) 
7.7 – 18.8 
(2) 
8.0-17.4 
(2) 
12.6  Sauces  7.0 – 12.3  
(4 ) 
6.0 – 26.0 
(12) 
7.7 – 35.8  
(10) 
8.1-34.5  
(14) 
5.9-28.5 
(6) 
14.1.4  Flavoured drinks  5.2-28.1 
(5) 
8.9 – 50.2 
(14) 
6.6 – 62.9  
(12) 
5.4 – 53.8  
(15) 
7.1-48.1 
(4) 
14.2 
Alcoholic beverages, 
including alcohol-free and 
low-alcohol counterparts       
8.5-18.5  
(4) 
6.3-14.4 
(3) 
15.1  Potato-, cereal-, flour- or 
starch-based snacks 
5.5-7.5  
(2) 
5.1 
(1) 
5.0 - 10.5  
(3)     
16  Desserts  12.1 – 14.9  
(2) 
5.2-10.4  
(5) 
8.4 
(1) 
5.4-6.2  
(2) 
7.6  
(1) 
17 
Food supplements as defined 
in Directive 2002/46/EC 
excluding food supplements 
for infants and young 
children 
       
5.4  
(1) 
(a): The total number of surveys may be greater than the total number of countries as listed in Table 3, as some countries 
submitted more than one survey for a specific population. 
 
2.9.4.  Main food categories contributing to exposure to Indigo Carmine (E 132) using the 
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Table 6:   Main food categories contributing to exposure to Indigo Carmine (E 132) using the brand-
loyal refined exposure scenario (> 5 % to the total mean exposure) and number of surveys in which 
each food category is contributing 
 
FCS 
Category 
number 
 
Foods 
Toddlers  Children  Adolescents  Adults  The 
elderly 
Range of % contribution to the total exposure  
(Number of surveys)
(a) 
01.4 
Flavoured fermented milk 
products including heat-
treated products 
23.5 - 78 
(6) 
6.8 - 28.8 
(10) 
6.7 - 9  
(5) 
5.4 - 23  
(8) 
5.7 - 24.2  
(5) 
03  Edible ices  9.6 (1)  7.8 - 7.8 
(1) 
10.9  
(1)       
05.2 
Other confectionery 
including breath freshening 
microsweets 
8.3 - 18.1 
(5) 
6 - 58.7 
(13) 
7.5 - 45.2 
(9) 
5.4 - 49.3 
(10) 
6.7 - 37.9 
(3) 
07.2  Fine bakery wares  7.6 - 54.1 
(6) 
8 - 71.5 
(13) 
7.7 - 67.3 
(11) 
10.2 - 58.9  
(13) 
8.5 - 59.5 
(6) 
12.5  Soups and broths  10.6 - 15.7 
(2) 
9.3 - 36  
(4) 
8.7 - 37.9 
(4) 
5.2 - 50.3 
(6) 
24.5 - 49.4  
(2) 
12.6  Sauces     
5.2 - 7.2 
(3) 
5 - 9.7  
(4) 
5.9 - 6.4 
(2) 
14.1.4  Flavoured drinks  6.7 - 43.1 
(5) 
6.9 - 47.2 
(14) 
7 - 53.2 
(12) 
9.1 - 75.4 
(15) 
6.1 - 68.9 
(6) 
14.2 
Alcoholic beverages, 
including alcohol-free and 
low-alcohol counterparts         6.5  
(1) 
5.1  
(1) 
15.1  Potato-, cereal-, flour- or 
starch-based snacks 
7.9  
(1)     6.5 - 8.9 
(2)      
16 
Desserts excluding products 
covered in category 01, 03 
and 04 
5.9 - 19.7 
(3) 
5.7 - 18.8 
(6) 
6 - 13.2  
(2) 
8.3 - 11.9 
(2) 
6.7 - 16.8 
(2) 
17 
Food supplements as defined 
in Directive 2002/46/EC 
excluding food supplements 
for infants and young 
children 
       5.8  
(1) 
6.1 - 24.5 
(2) 
(a): The total number of surveys may be greater than the total number of countries as listed in Table 3, as some countries 
submitted more than one survey for a specific population. Re-evaluation of Indigo Carmine (E 132) as a food additive  
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Table 7:   Main food categories contributing to exposure to Indigo Carmine (E 132) following the 
non-brand-loyal exposure scenario (> 5 % to the total mean exposure) and number of surveys in which 
each food category is contributing 
FCS 
Category 
number 
Foods 
Toddlers  Children  Adolescents  Adults  The 
elderly 
Range of % contribution to the total exposure  
(Number of surveys)
(a) 
01.4 
Flavoured fermented milk 
products including heat-
treated products 
13.4 - 76.5 
(6) 
5.5 - 37.2 
(12) 
5.1 - 10.6 
(6) 
5.2 - 34.1  
(9) 
9 - 28.7 
(3) 
03  Edible ices  8.4  
(1) 
5.7 - 8.6 
(3) 
6.9  
(1)       
05.2  Other confectionery including 
breath freshening microsweets     8.6 - 10.3 
(2) 
5.3 - 7.7  
(2) 
7.7 - 8.9 
(2) 
5.5  
(1) 
07.2  Fine bakery wares  5.6 - 67.9 
(7) 
6.3 - 74.2 
(15) 
5.3 - 70.8 
(12) 
9.5 - 
63.3 (14) 
16.6 - 63.6 
(6) 
12.5  Soups and broths  6.7 - 30.4 
(3) 
6.5 - 46.4 
(7) 
5.7 - 45.6 
(6) 
9.3 - 57 
(7) 
8.2 - 55.1 
(3) 
12.6  Sauces  5.6  
(1) 
5.5 - 12 
(9) 
7.1 - 17.1 
(7) 
5 - 21 
(12) 
6.7 - 12.8 
(5) 
14.1.4  Flavoured drinks  7.6 - 21.8 
(5) 
6.4 - 60.1 
(14) 
7.7 - 70.3 
(12) 
5.5 - 
62.2 (15) 
5.7 - 52.1 
(4) 
14.2 
Alcoholic beverages, 
including alcohol-free and 
low-alcohol counterparts 
         5.1 - 5.2 
(2) 
5.3 - 5.6 
(2) 
15.1  Potato-, cereal-, flour- or 
starch-based snacks 
5.2 - 8.4 
(2)     5.5 - 11.7 
(3) 
5.5 - 5.7 
(2)    
16  Desserts excluding products 
covered in category 1, 3 and 4 
13.8 - 46.2 
(3) 
6.1 - 35.3 
(9) 
5.7 - 28.6 
(7) 
6 - 25.1 
(8) 
8.5 - 30.8 
(3) 
17 
Food supplements as defined 
in Directive 2002/46/EC 
excluding food supplements 
for infants and young children 
         11.4 (1)  32.1 (1) 
(a) The total number of surveys may be greater than the total number of countries as listed in Table 3, as some countries 
submitted more than one survey for a specific population. 
 
The Panel noted that, considering all the authorised uses of Indigo Carmine (E 132) as a food additive, 
both reported use levels and quantified analytical results were reported only for the food categories of 
chewing gum, flavoured drinks and desserts. For several food products for which the use of Indigo 
Carmine is authorised e.g. flavoured fermented milk products, seasonings and condiments, mustard, 
soups and broths, sauces, cider and perry, aromatised wine based-products and other alcoholic drinks, 
no usage were reported and also reported analytical data showed only limited sample sizes (n<20). In 
addition, the Panel further noted that for some other authorised food categories such as edible ices, 
fine bakery wares, fish roe, spirit drinks, potato-, cereal, flour-, or starch-based snacks and processed 
nuts, no usages had been reported by industry, while positive analytical results (> LOQ) were obtained 
from the analytical data. 
For the main contributing food categories of fine bakery wares and flavoured drinks, the analytical 
data comprised around 1000 samples and levels were found to be far below the MPL. Moreover, for 
the  food  category  of  flavoured  fermented  milk  products  (FCS  01.4),  although  being  a  major 
contributor to the total exposure estimated using the regulatory maximum level exposure assessment 
scenario, no usage was reported by industry, and none of the 10 analytical results reported for this 
food category (FCS 01.4) were quantified. For the additional food categories (i.e. seasonings and 
condiments, mustard, soups and broths, sauces, cider and perry, aromatised wine based-products, other Re-evaluation of Indigo Carmine (E 132) as a food additive  
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alcoholic drinks) for which no usage data or positive analytical values were reported and thus not 
available for use in the refined assessment, their contribution to the total exposure to Indigo Carmine 
in the MPL scenario is low.  
2.9.5.  Uncertainty analysis 
Uncertainties in the exposure  assessment  of  Indigo  Carmine  (E  132)  have  been  discussed  above. 
According to the guidance provided in the EFSA opinion related to uncertainties in dietary exposure 
assessment  (EFSA,  2007),  the  following  sources  of  uncertainties  have  been  considered  and 
summarised below: 
Table 8:   Qualitative evaluation of influence of uncertainties on the dietary exposure estimate 
Sources of uncertainties  Direction
(a) 
Consumption data: different methodologies/representativeness/under 
reporting/misreporting/no portion size standard  +/- 
Use of data from food consumption survey of few days to estimate long-term 
(chronic) exposure  + 
Correspondence of reported use levels to the food items in the EFSA 
Comprehensive Food Consumption Database: uncertainties on which precise 
types of food the levels refer to 
+/- 
Concentration data: levels considered applicable for all items within the entire 
food category, exposure calculations based on the maximum or mean levels 
(reported use from industries or analytical data from MS) 
+ 
Concentration data: levels above the MPLs or on non authorised food 
categories not considered  - 
Uncertainty in possible national differences in use levels of food categories, 
concentration data not fully representative of foods on the EU market  +/- 
(a):  +  =  uncertainty  with  potential  to  cause  over-estimation  of  exposure;  -  =  uncertainty  with  potential  to  cause 
underestimation of exposure. 
 
3.  Biological and toxicological data 
The biological properties of Indigo Carmine have been previously evaluated by JECFA in 1969 and 
1975 (JECFA, 1969, 1975). The present opinion briefly reports the major studies evaluated in these 
reports. Additional information has been identified from the literature and the calls for data. 
3.1.  Absorption, distribution, metabolism and excretion 
3.1.1.  In vitro 
Incubation of 
35S-labelled Indigo Carmine with intestinal contents of rats for 48 hours was investigated 
by Lethco and Webb (1966). This study resulted in loss of colour and formation of isatin-5-sulphonic 
acid and 5-sulphoanthranilic acid (further details were not available). The authors suggested that, by 
the action of intestinal bacteria, isatin-5-sulphonic acid and 5-sulphoanthranilic acid might be formed 
which could be absorbed after formation. 
Singh et al. (1993) measured the degradation of Indigo Carmine (1 mg) in the caecal microflora of 
Wistar rats (0.2 ml caecal extract). The time period required to degrade 50 % of the original colour 
concentration was 54 minutes. This study indicated also that Indigo Carmine was transformed by 
caecal microflora to four unidentified fluorescent metabolites. 
3.1.2.  In vivo 
A series of studies by Lethco and Webb (1966) used radiochemically pure 
35S-labelled Indigo Carmine 
(FD&C Blue No 2) to investigate the stability of the radiolabel, biliary excretion of intravenously Re-evaluation of Indigo Carmine (E 132) as a food additive  
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administered 
35S-labelled Indigo Carmine and excretion of orally administered 
35S-labelled Indigo 
Carmine.  
After intravenous injections of 1.4 mg/kg bw 
35S-labelled Indigo Carmine to bile-duct-cannulated rats 
with ligated urethras, the animals were maintained under anaesthesia for 6 hours and urine was taken 
directly from the bladder. Within 6 hours 63 % of the radioactivity appeared in the urine and about 
10 % in the bile, almost all the biliary excretion occurred in the first 30 minutes. The break-down 
products isatin-5-sulphonic acid and 5-sulphoanthranilic acid (Figure 2) were identified in the bile 
samples from 2 hours onwards and in the urine from 1 and 2 hours after dosing. In urine, 71 % of the 
excreted radioactivity was the parent compound with 19 % as isatin-5-sulphonic acid and 10 % as 5-
sulphoanthranilic  acid.  Neither  isatin-5-sulphonic  acid  nor  5-sulphoanthranilic  acid  were  found  in 
urine  spiked  with 
35S-labelled  Indigo  Carmine  after  6  hours  standing  at  room  temperature.  This 
indicates that their formation did not occur after the radioactivity was excreted. Small amounts of 
these two metabolites appeared in bile after 4 hours. 
 
Figure 2:   Structural formulae of isatin-5-sulphonic acid and 5-sulphoanthranilic acid 
Following oral administration of 5, 25 and 50 mg/rat 
35S-labelled Indigo Carmine to groups of 4 male 
rats (based on the cited body weight range for the rats these are approximately equivalent to 10.4-14.5, 
52-72 and 104-145 mg/kg bw respectively), only 1.6 to 2.1 % of the radioactivity appeared in urine 
and between 61 % and 80 % was recovered in faeces within 3 days. Urinary and faecal excretion was 
essentially identical at all three doses. Since only 0.004 % of an oral dose of 20 mg/rat was excreted 
via bile in an additional experiment, the authors concluded that the oral experiment suggested a poor 
absorption of Indigo Carmine from the gastrointestinal tract. Following oral administration, the urine 
contained  low  amounts  of  radioactivity  as  Indigo  Carmine,  isatin-5-sulphonic  acid  and  5-
sulphoanthranilic acid (0.53, 0.63 and 0.28 % of the radioactivity, respectively).  
In an additional experiment, the oral administration of 5-sulphoanthranilic acid at doses of 1, 10 and 
100 mg/animal resulted in the excretion of 19.8 % to 27.7 % of the dose in urine in 48 hours. From 
these  data,  the  authors  concluded  that  “it  is  surprising  that  relatively  large  percentages  of  5-
sulfoanthranilic acid were found in the urine following its oral administration, indicating that 5-
sulfoanthranilic acid is absorbed to a greater extent than FD&C blue no. 2 (Indigo Carmine)”. 
Overall, in vivo studies demonstrated that radioactivity from 
35S-Indigo Carmine was poorly detected 
in urine (1.6 to 2.1 % of the radioactivity) after oral administration in rats. Moreover, incubation of 
35S-Indigo Carmine with intestinal contents of rats for 48 hours suggested that isatin-5-sulphonic acid 
and 5-sulphoanthranilic acid are metabolites formed by intestinal bacteria. By comparison to the data 
obtained  after  intravenous  administration,  the  Panel  considered  that  the  data  available  on  the 
absorption,  metabolism  and  excretion  of  Indigo  Carmine  indicated  that  Indigo  Carmine  or  its 
metabolites  were  poorly  absorbed.  However,  the  Panel  noted  that  both  identification  of  faecal 
metabolites and tissue distribution of radioactivity were not investigated in these studies. Re-evaluation of Indigo Carmine (E 132) as a food additive  
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3.2.  Toxicological data 
3.2.1.  Acute oral toxicity 
The JECFA evaluation (1975) briefly mentioned some studies on the acute oral toxicity of Indigo 
Carmine. LD50 values were 2500 mg/kg bw in mice (US FDA, 1969, as referred to by JECFA, 1975) 
and 2000 mg/kg bw in rats (Lu and Lavalleé, 1964, as referred to by JECFA, 1975). 
3.2.2.  Short-term and subchronic toxicity 
3.2.2.1.  Short-term toxicity studies 
In a study by Aboel-Zahab et al. (1997) male Albino rats (strain not specified) received 800 mg/kg 
bw/day in the diet of a mixture that contained Brown HT and Indigo Carmine. The composition of the 
mixture was not specified as it was stated to be a company secret and, therefore, the concentration of 
each colour was not reported. The Panel considered that the results of this study cannot be used for the 
hazard  characterisation,  since  the  experimental  animals  have  been  exposed  to  a  mixture  of  food 
colours in which the dose level of each colour has not been specified. 
Weanling large white pigs (3/sex/group) were given Indigo Carmine at dietary doses of 0, 150, 450 
and 1350 mg/kg bw/day for 90 days. Haemoglobin levels and red cell counts were slightly reduced 
after 45 and 90 days in males at the highest dose tested. There was no effect of treatment on growth, 
urine and serum analysis or organ weights. Histological examination revealed liver abscesses in one 
male in the low-dose group but this was considered not to be treatment-related. No other abnormalities 
were seen (Gaunt et al., 1969). 
Adult male Swiss albino (B-6 strain) mice (5 animals/group) were fed with 0, 17 and 39 mg Indigo 
Carmine/kg bw/day for a period of 42 days (Dixit and Goyal, 2013). Indigo Carmine was given orally 
mixed with the standard diet. The test material (E 132; FD&C Blue # 2; CI 73015), used in the present 
study was procured from a local market
21.. Whether the test material met the EU specifications for the 
food additive E 132 or contained contaminants was not determined. Only the following parameters 
were studied: body weights, organ weights, histopathology of the testes, sperm density and sperm 
motility. The animals fed with the dye showed a statistically significant increase in their body weights 
at both dose levels. In addition, a significant decrease was observed in the average weight of the testes 
at both dose levels. Histopathological examination of the testes demonstrated a significant reduction in 
the average diameter of the seminiferous tubules at both dose levels. A marked reduction in testicular 
sperm density was found to be statistically non-significant at the low dose but significant at the high 
dose,  when  compared  to  the  control  group.  According  to  the  authors,  Indigo  Carmine  caused  a 
significant decrease in the sperm motility at both doses. Severe histopathological changes in the testis 
architecture at both the doses were described. At low dose, Indigo Carmine caused thickening of the 
tubular basement membrane, arrest of spermatogenesis at the spermatid stage and the debris from 
necrotic sperm was evident within the tubular lumen. At high dose, Indigo Carmine caused dissolution 
of the tubular basement membrane and exfoliation of cells in the lumen, leading to complete testicular 
blockage. Cytoplasmic vacuolation and pycnosis were also prominent. The Panel noted limitations in 
the design of the study and the lack of information on the identity of the test material used in the study. 
The authors stated that the dose range was based on the LD50 of the test substance. However, the 
percentage of the LD50 used  was not stated. The Panel noted that the doses of 17 and 39 mg/kg 
bw/day were low compared to the LD50 of Indigo carmine (E132) of 2500 mg/kg bw. The Panel 
considered that a mouse between the age of 4-5 weeks (as used in this study) should grow more than 
1.6 g as indicated for the control group. Normal feed intake in mice is 3-4 g/day. It was indicated by 
the authors that the control mice consumed a diet of 10 g/day. The authors reported that the mice were 
fed 5 g of diet containing Indigo Carmine and 5 g normal diet. The Panel noted that, the authors did 
                                                       
21   The test material was reported by the authors to have been manufactured and packed by ASES Chemical  
  Works Laboratory chemical division, Jodhpur. 
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not state whether the mice of the control and test groups received diet from the same batch. This 
method of feeding deviates from commonly used methods and also from the method described in the 
OECD guidelines. In addition, the Panel noted that the authors did not state whether the diet was 
analysed for the concentration of the test substance and contaminants. 
The Panel noted that no NOAEL could be identified in this study and the lowest observed adverse 
effect level (LOAEL) was 17 mg/kg bw/day, the lowest dose level tested. 
3.2.2.2.  Subchronic toxicity 
No subchronic toxicity studies were available with Indigo Carmine. 
The JECFA evaluation described a short-term study conducted with isatin-5-sulphonic acid, one of the 
metabolites  of  Indigo  Carmine.  Isatin-5-sulphonic  acid  was  fed  to  groups  of  3-week-old  rats 
(10/sex/group), at levels of 0, 0.25, 0.5, 1 and 2 % (equivalent to 0, 125, 250, 500 or 1000 mg/kg 
bw/day) for 13 weeks. Gross and histopathology examinations were conducted. The "no-effect" level 
of  the  compound  was  considered  by  JECFA  to  be  2 %  equivalent  to  1000 mg  isatin-5-sulphonic 
acid/kg bw/day (US FDA, 1969, as referred to by JECFA, 1975). 
3.2.3.  Genotoxicity 
3.2.3.1.  In vitro 
Bacterial mutagenicity of Indigo Carmine was studied using Salmonella typhimurium strains TA98, 
TA100, TA1535, TA1537, TA1538 with and without metabolic activation (Auletta et al., 1977; Bonin 
et al., 1980; Brown et al., 1978; Cameron et al., 1987; Ishidate et al., 1984). No mutations were 
observed. The Panel noted, however, that neither the TA102 strain nor any Escherichia coli strain was 
used in the standard plate or preincubation assays. Lück and Rickerl (1960, as referred to by JECFA, 
1975) reported that Indigo Carmine did not induce reverse mutations in two Escherichia coli strains. 
However, the study only used a single concentration of Indigo Carmine (5 g/L), it was performed only 
in the absence of metabolic activation and was not compliant with current standard protocols . Indigo 
Carmine (10 mg/mL and liver S9 fraction) did not damage DNA in a rec and pol assay using strains of 
Escherichia coli (Haveland-Smith and Combes, 1980).  
In the study by Ishidate et al. (1984), Indigo Carmine was tested in a chromosomal aberration test in 
vitro using the Chinese hamster fibroblast CHL cell line. The test results were reported only for the 
maximum concentration and only for one sampling time. At an Indigo Carmine concentration of 12 
mg/mL the incidence of polyploid cells was 10 % and the frequency of cells with structural aberrations 
was 3 % at 24 hours after treatment. The frequency of chromosomal aberrations in the control cultures 
was not presented but the frequency of cells with polyploidy was largely in excess when compared to 
the  results  obtained  with  other  compounds  which  were  considered  negative  by  the  authors. 
Accordingly, the authors considered the result obtained with Indigo Carmine as a positive result. The 
Panel  noted  that  the  effect  was  observed  at  an  excessive  concentration  of  12 mg/mL  (equal  to 
26 mmol/L) and that no information on cytotoxicity was reported. Therefore, the Panel did not agree 
with the authors and considered that the result was inconclusive.  
The Panel noted that the following four in vitro studies have been published after the JECFA and the 
SCF evaluations. 
In a mouse lymphoma assay performed with Indigo Carmine by Cameron et al. (1987), there was an 
increase in mutation frequency (up to 277 mutants/10
6 cells compared to 53 mutants/10
6 cells in the 
negative control) which exceeded the “global evaluation factor” of 126 mutants/10
6 cells with no clear 
dose-relationship  in  the  presence  of  metabolic  activation,  and  no  response  without  metabolic 
activation. However, in the presence of S9 only cytotoxic concentrations were tested ranging from 92 
to 556 µg/mL (equal to 0.2-1.2 mmol/L). All concentrations tested induced a marked cytotoxicity 
expressed as relative total growth (RTG) ranging from 23 % at the lowest concentration to 10-13 % at Re-evaluation of Indigo Carmine (E 132) as a food additive  
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the highest concentration. The authors considered the result as indeterminate and noted that re-testing 
would be required in order to determine whether this result can be interpreted as a mutagenic response. 
The Panel agreed with the authors and noted that the absence of a dose response relationship in mutant 
frequency may be related to inadequate selection of concentrations since the lowest concentration 
already caused cytotoxicity.  
Kornbrust and Barfknecht (1985) tested a range of food-dyes in an in vitro rat Hepatocyte Primary 
Culture/DNA Repair (HPC/DR) assay and, to a limited extent, in an in vivo/in vitro HPC/DR assay. It 
was found that Indigo Carmine (Acid blue 74) did not produce any detectable DNA repair increase.  
The DNA damaging potential of Indigo Carmine (purity not reported) was investigated in an in vitro 
Comet assay using MCF-7 breast cancer cells in order to assess the safety of the use of this dye for 
clinical purposes (Masannat et al., 2009). The cells were exposed for five minutes at concentrations 
from 0.001 to 0.4 % (equal to 0.02-8.6 mmol/L). Formamidopyrimidine DNA glycosylase (FPG) was 
incorporated into the Comet assay in order to detect purine oxidation products such as 8-oxoguanine. 
At the concentration of 0.4 %, Indigo Carmine caused a slight increase in DNA damage, expressed as 
a percentage of tail DNA, compared with untreated control cells (6.81 % vs 4.04 %). The difference, 
however, did not reach statistical significance.  
To investigate the effect of Indigo Carmine on the induction of DNA damage, Davies et al. (2006) 
conducted a Comet assay without and with FPG in order to demonstrate DNA oxidative damage in a 
human colonic adenocarcinoma cell line (CaCo2 cells) and before and after dye-spraying in human 
colonic cells taken at biopsy from 10 patients undergoing colonoscopic examination. The CaCo2 cells 
were exposed for two minutes at a concentration of 0.1 % (equal to 2 mmol/L, purity not reported). 
The  mucosal  biopsy  samples  were  taken  from  the  same  area  of  the  colon  before  and  after  the 
application of 2 mL of 0.1 % Indigo Carmine dye onto the colonic mucosa. In both the CaCo2 cell line 
and  the  human  colonic  cells  (obtained  from  patients  before  and  after  administration  of  Indigo 
Carmine) no increase in DNA strand breaks was observed. The Panel noted that the exposure and 
sampling times were not reported for the biopsy samples, therefore the reliability of the negative result 
is limited. 
3.2.3.2.  In vivo 
The Panel noted that none of the in vivo studies were available for the JEFCA and SCF evaluations. 
Male  Swiss  albino  mice  (10  animals  per  group)  received  daily  doses  of  Indigo  Carmine  alone 
(2 mg/kg bw/day) or Indigo Carmine (1 mg/kg bw/day) and nitrite (1 mg/kg bw/day) in combination 
for 30 days in order to investigate bone-marrow chromosomal aberrations (Giri et al., 1986). A total of 
600 metaphases were scanned from 10 animals.  When Indigo Carmine was administered alone, a 
statistically significant increase in the frequency of chromosomal aberrations (mainly breaks)  was 
reported by the authors. However, the study shows significant shortcomings which include presence in 
the vehicle control of two cells with more than 10 aberrations per cell out of 600 cells scored. This 
outcome could have been caused either by an unhealthy status of animals or the use of an unusual 
method  for  preparation  of  slides  (“flame  dried  preparation”),  which  could  affect  the  integrity  of 
chromatin  thus  generating  artifactual  breaks.  The  Panel  also  noted  that  -  considering  the  limited 
absorption of test compound in vivo - the dose administered was very low (2 mg/kg bw/day) although 
no rationale for its selection was supplied by the authors. Furthermore, no historical control data were 
provided to assess the biological relevance of the results obtained. On this basis, the Panel considered 
that the study was not reliable for risk assessment. 
Groups of male mice were administered a single i.p. injection with Indigo Carmine alone at dose 
levels of 5, 10, 25, 50 and 100 mg/kg bw and in combination with nitrite at concentrations equivalent 
to one-half of the concentrations of Indigo Carmine when administered alone, to evaluate induction of 
Sister Chromatid Exchanges (SCEs) in bone-marrow cells (Giri and Mukherjee, 1990). Statistically 
significant increases in the frequency of SCEs were observed at dose levels of 25, 50 and 100 mg/kg Re-evaluation of Indigo Carmine (E 132) as a food additive  
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bw of Indigo Carmine when administered alone. Increases over control were small (3.4 – 4.6 SCE per 
cell), and within the range normally found in negative control animals for this assay. The Panel also 
noted limitations in the selection of dose-levels and - for the evaluation of data - no historical control 
data  were  supplied  to  assess  biological  relevance  of  results  obtained.  On  this  basis,  the  Panel 
considered the outcome of this study not biologically relevant. 
Durnev  et  al. (1995)  studied  the  mutagenic  activity  of  6  food  colours, including  Indigo  Carmine 
(E 132) in an in vivo chromosomal aberration assay. The substances were given orally to C57BL/6 
mice (5 animals/group) for a period of 5 days, in daily doses of 1.4 or 14 mg/kg bw. The animals were 
sacrificed  6  hours  after  the  last  dose.  The  concurrent  control  group  also  consisted  of  5  animals. 
Analysis  of  metaphase  spreads  (500/group)  from  bone-marrow  from  treated  animals  revealed  no 
increase in the number of cells bearing chromosomal damage compared to the concurrent control. The 
Panel noted that the study was not performed according to OECD guidelines (e.g. with respect to the 
number of dose levels and sampling time), therefore the Panel considered that the reliability of this 
negative result is limited.  
Sasaki  et  al.  (2002)  studied  the  genotoxicity  of  39  chemicals  currently  in  use  as  food  additives 
including Indigo Carmine in an in vivo Comet assay. Groups of 4 male ddY mice were treated once 
orally with Indigo Carmine at the limit dose of 2000 mg/kg bw. The glandular stomach, colon, liver, 
kidney, urinary bladder, lung, brain and bone-marrow were analysed for DNA damage 3 and 24 hours 
after treatment. Indigo Carmine did not yield a statistically significant increase in DNA damage in any 
organ. 
Following a call for scientific data on Indigo Carmine launched by EFSA for new genotoxicity data, 
an  in  vivo  study  on  induction  of  micronuclei  in  the  bone  marrow  of  treated  rats  was  performed 
(Whitwell, 2013). The study was conducted in compliance with the OECD guideline 474
22. Groups of 
six rats were treated by oral gavage  twice, with a 24 hour interval between each dose. The animals 
received the vehicle only (1 % methylcellulose) or Indigo Carmine
23 (E132) at 300, 2000 and 3000 
mg/kg bw/day. Cyclophosphamide was used as positive control substance at  20 mg/kg bw/day. 
Animals were sacrificed at 48 hours. Results obtained indicate that no significant incr eases in the 
group mean frequencies of micronucleated polychromatic erythrocytes (MN PCE) were observed in 
any Indigo Carmine treatment group compared to the relevant concurrent negative control group. A 
slight increase in group mean frequency of MN PCE co mpared to the untreated control group was 
observed at 300 mg/kg bw/day (0.12 % - 0.24 %) which was mainly attributable to a single animal. It 
should be noted here that the number of PCE scored per animal for analysis of micronuclei was 4000 
instead of 2000 PCE as recommended by OECD Guideline 474. The author justified this action as an 
“aid in data interpretation”. The Panel did not consider this extra scoring a shortcoming since a greater 
number of cells was analysed thus increasing the statistical power. The Panel noted that there was no 
proof of target tissue exposure since there was no evidence of test article related bone marrow toxicity 
and toxicokinetic data indicated only a minor absorption from the gastrointestinal tract. However, the 
Panel considered that Indigo Carmine at the concentration of 2000 mg/kg bw/day did not induce DNA 
damage at first site of contact (i.e. the glandular stomach) in an in vivo Comet assay performed by 
Sasaki et al. (2002).  
Overall the Panel concluded that based on the available data, Indigo Carmine does not raise concern 
for genotoxicity. 
                                                       
22  OECD (1997). “Genetic Toxicology: Mammalian Erythrocyte Micronucleus Test”. In OECD Guidelines for the testing  
  of chemicals. OECD Paris, Test Guideline 474. 
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3.2.4.  Chronic toxicity and carcinogenicity 
3.2.4.1.  Mice 
Two long term/carcinogenicity studies in mice were available. 
Groups of Charles River CD1 mice (30/sex/group; 60/sex/controls) received diets containing 0, 0.2, 
0.4, 0.8 or 1.6 % Indigo Carmine (equivalent to approximately 0, 300, 600, 1200, or 2400 mg/kg 
bw/day according to the authors) for 80 weeks (Hooson et al., 1975). The only effect noted was a 
slight anaemia in the 0.8 and 1.6 % groups. Furthermore, no effects were observed with regard to 
bodyweight gain, organ weights, deaths, histopathological examination, or tumour incidence. Indigo 
Carmine did not exert any carcinogenic effect. Based on these results the authors identified a NOAEL 
of approximately 600 mg/kg bw/day. The Panel agreed with this NOAEL.  
In  a  long-term  toxicity/carcinogenicity  study  by  Borzelleca  and  Hogan  (1985),  42-day  old  mice 
(Charles Rivers CD1 COBS ISC derived) (60/sex/group, 2 control groups) were fed Indigo Carmine 
(FD&C blue No 2
24) at dietary concentrations of 0, 0.5, 1.5 or 5.0  % (equal to 0, 825, 2477 and 
8259 mg/kg bw/day in male and 0, 945, 2836 and 9456 mg/kg bw/day in female) for a maximum of 23 
months. Observations of deaths, morbidity and gross signs of toxicol ogical effects were conducted 
twice daily. Detailed physical examinations for signs of toxicity and palpation for masses were 
conducted weekly. Body weight and food consumption were determined weekly through the first 14 
weeks, biweekly for weeks 16-26 and monthly thereafter. Ten animals of each group were randomly 
selected for haematology tests at months 3, 6, 12 and 18 of the study. The parameters evaluated were 
haemoglobin, erythrocyte and total and differential leucocyte counts and erythrocyte morpholog y. 
Necropsies were conducted on all animals dying spontaneously, sacrificed in a moribund condition, or 
on schedule. A complete histopathology study was conducted on all animals from the 2 control groups 
and from the highest dose group (5 %). Histopathological examination was only carried out on tissues 
from any low-dose or mid-dose animal with a gross lesion or mass. Organ weights were recorded for 
brain, gonads, kidneys, liver, spleen and thyroid, and relative organ weights were calculated.  In the 
treated  animals at all doses,  there was  a moderate incidence of blue -green discolouration of the 
gastrointestinal tract with occasional concomitant involvement of the liver, gall -bladder and urine. 
This discolouration was attributed to the Indigo Carmine (Borzelleca and Hogan, 1985).  
Other grossly observable abnormalities occurred randomly without relation to treatment or dose group. 
The most frequent were uterine enlargement by cystic and/or polypoid change as well as the presence 
of ovarian cysts. These changes are considered to be associated with ageing. Focal discolouration (red, 
tan, gray, brown)  occurred at a moderate incidence in the heart, lungs, kidneys, 1iver, uterus and 
spleen. Irregularities of shape (noted in  the  kidneys and liver), enlargements of  the  spleen and 
mesenteric nodes occurred less frequently. Other observed changes occurred sporadically.  
The changes thus mentioned were considered to be incidental findings as expected in ageing mice and 
were not associated with the test compound.  
Histopathological examination revealed several non-neoplastic changes including amyloidosis of the 
kidney, ileum, duodenum, adrenal glands, ovaries, spleen and liver. Myocardial degeneration with 
frequent concomitant atrial thrombosis was noted, as were hyperplastic changes of the uterus and 
lymphoreticular  tissue. These  changes  were  of  the type  and  incidence  common  in  populations  of 
ageing laboratory mice and were considered by the authors unrelated to the treatment.  
Neoplastic lesions were found in the lungs, liver, lymph nodes and uteri of mice from all groups. The 
lymphoid  neoplasms  were  heteromorphic and  generally  multicentric,  and  involved  the  spleen and 
mesenteric  and  mediastinal  lymph  nodes.  Neither  the  incidence  of  neoplasms  nor  their  primary 
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locations  and  histopathological  characteristics  differed  significantly  between  control  and  treated 
animals. There were no statistically significant differences for time-to-tumour analyses between the 
control and treated animals.  
In conclusion, microscopical evaluation of selected tissues revealed a variety of randomly distributed 
neoplastic, degenerative, hyperplastic and inflammatory changes usually encountered in ageing mice. 
These changes occurred without relationship to dose and were considered by the study authors to be 
unrelated to the dietary administration of Indigo Carmine. 
The  authors  concluded  that  there  were  no  consistent  biologically  significant  compound-  or  dose-
related effects on behaviour, morbidity, haematology or general physical observations and that all of 
the neoplasms were of types common in ageing mice. It was therefore concluded that this lifetime 
exposure of mice to Indigo Carmine did not demonstrate carcinogenic or toxic effects. According to 
the authors, the NOAEL in this study was 5 % in the diet (the highest dose tested) providing an 
average  intake  of  8259 mg/kg  bw/day  for  males  and  9456 mg/kg  bw/day  for  females.  The  Panel 
agreed with this conclusion. 
3.2.4.2.  Rats 
Four long term/carcinogenicity studies in the rat were available (Oettel et al., 1965; Hansen et al., 
1966; Borzelleca et al., 1985).  
Twenty  six  female  and  fifteen  male  Wistar  rats  with  a  body  weight  of  50 g  at  the  start  of  the 
experiment (P-generation) were fed a diet containing 1 % Indigo Carmine, which, according to the 
authors, corresponded to an intake of 0.1-0.2 g Indigo Carmine/animal/day (equivalent
25 to 500 mg/kg 
bw/day) (Oettel et al., 1965). The control group for the P -generation consisted of 20 females and 15 
males. After six months, some animals (no specification of numbers) of th e P-generation treatment 
group or control group respectively, were mated. During lactation dams were fed a diet without Indigo 
Carmine. Rats were weaned 2 –3  weeks  after  birth  at  a  body  weight  of  25–35 g  and  fed  a  diet 
containing  1 %  Indigo  Carmine  (treatment  group  of  F1  generation:  20  females,  20  males)  or  no 
colouring  material  (control  group  for  the  F1  generation:  5  females,  5  males).  To  investigate 
spontaneous tumour development an additional control group of 100 female and 100 male Wistar rats 
was fed the control diet. Administration of Indigo Carmine to the rats of the P and F1 generation was 
stopped after 2 years of treatment. All animals were observed until they died spontaneously or were 
killed  when  moribund.  After  macroscopical  inspection  neoplasms  and  conspicuous  alterations  of 
tissues were examined microscopically.  
The authors combined the results of the treated animals of the P and F1 generation and of the control 
animals of the two generations, since there were no differences observed in behaviour, growth, and 
survival time. No adverse effects were observed in the animals treated with Indigo Carmine. Body 
weight gains in treated and control animals were reported to be equivalent.  
In the treated groups of the P or F1 generation no malignant tumours were detected. Two out of 125 
males and 4 out of 125 females of the control group died due to sarcomas at different locations. 
Mammary gland fibroadenomas were detected in one male and three females of the treated animals of 
the P and F1 generation and in one female of the control animals of the P and F1 generation. In the 
additional control group 10 mammary gland fibroadenomas were found in 9 out of 100 females.  
The authors concluded that rats fed at a concentration of 1 % Indigo Carmine in the diet did not show 
any treatment-related pathological damage or tumour development (Oettel et al., 1965).  
In a study by Hansen et al. (1966), ten groups of 24 Osborne-Mendel weanling rats equally divided by 
sex,  received  either  0.0,  0.5,  1,  2  or  5 %  Indigo  Carmine  (equivalent  to  0,  250,  500,  1000  and 
2000 mg/kg bw/day) in their diets for 2 years. Animals were weighed weekly, and mortalities and 
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abnormalities were recorded. Blood counts (white blood cell count, haemoglobin, haematocrit and 
differential  cell  count)  were  performed  on  10  animals  at  each  dose  at  3,  11,  17  and  22  months. 
Survivors were autopsied and organ weights recorded for the heart, liver, spleen, kidney and testes. 
Detailed microscopical examination of the heart, lung, liver, small intestine, colon, bone marrow, leg 
bone and muscle, urinary bladder, kidney, pancreas, thyroid, adrenal, testis and prostate or ovary and 
uterus was conducted. No effects were observed on mortality, haematology or on weights of the heart, 
liver, kidney, spleen and testis of the animals that received Indigo Carmine at dietary levels up to 5 %. 
The male animals of the two higher doses showed statistically significant growth inhibition. Slight but 
statistically non-significant growth depression was observed in the females at the same dosages. There 
was no treatment-related change in mortality, organ weights, haematology, or gross and microscopical 
examination. The NOAEL of this study was considered by the Panel to be 1 % in the diet, equivalent 
to 500 mg Indigo Carmine/kg bw/day based on growth inhibition at the highest dose level. 
Indigo Carmine was fed to rats in the diet in a long-term toxicity/carcinogenicity study performed in 
F1 animals of a reproductive toxicity study (Borzelleca et al., 1985). Indigo Carmine (FD&C Blue No 
2
26) was administered to groups of  male and female Charles River CD albino rats (70 animals per sex 
group) at levels of 0.5, 1.0 and 2.0 % (equal to 304, 632 and 1282 mg/kg bw/day in male rats and 363, 
775 and 1592 mg/kg bw/day in female rats). Two control groups, each containing 70 rats (F1) of each 
sex,  received  a  basal  diet.  The  maximum  duration  was  30  months.  A  complete  histopathological 
analysis was conducted on all animals from the two control groups and from the highest dose group 
(2 %). The following tissues were examined: adrenals, aorta, bone and marrow (femur), blood smear, 
brain, oesophagus, eyes, heart, intestine (caecum, colon, duodenum and ileum), kidneys, liver, lung 
and mainstem bronchi, lymph nodes, mammary gland, nerve, ovaries, pancreas, pituitary, prostate, 
salivary  gland,  seminal  vesicles,  skeletal  muscle,  spleen,  stomach,  testes,  thymus,  thyroid  with 
parathyroids, trachea, urinary bladder, uterus, any tissue with gross changes of uncertain nature and 
any tissue masses or suspect tumours. If a potential effect was noted in a tissue, then that tissue was 
examined histologically in all animals. No consistent compound-related biologically adverse effects 
were noted. There were random statistically significant differences from the controls with respect to 
body weight, food consumption and clinical chemistry tests. Food consumption by the test groups 
showed a dose-related increase, probably due to the non-nutritive character of the colour. Age-related 
testicular atrophy of the seminiferous tubules, accompanied by oligospermia or aspermia, was present 
in male rats of all groups. These lesions were randomly distributed in treated and control animals and 
were not dose- related. Increased incidences of pituitary neoplasms (female and male), transitional-cell 
neoplasms of the urinary bladder (male) and malignant mammary-gland neoplasm (carcinoma and 
adenocarcinoma, female) were not statistically significantly different from controls.  
A statistically significant (p < 0.05) increase in the incidence of malignant mammary gland tumours 
was noted in the high-dose male rats. The highest dose group had an incidence of 7.8 % (5/51 animals) 
of carcinomas/adenocarcinomas while the combined control groups had an incidence of 3.5 % (4/114 
animals). 
Male rats that received the highest level of Indigo Carmine showed an increased incidence of gliomas. 
Since each control group had a glioma incidence of 2.9 % (2/70 animals), the groups were combined 
for statistical analysis (4/140 animals). The low-dose and mid-dose had an incidence of 2.9 % (2/70 
animals). The high-dose had an incidence of 9.9 % (7/71). The difference in incidence of gliomas 
between the control groups and the high-dose male rats was statistically significant p < 0.05. There 
was no increased incidence of gliomas in female rats. Two gliomas were observed in one female 
control group and one glioma was observed in the high-dose females. The authors observed that for 
the gliomas observed in treated animals, there was no clear dose-effect relationship, nor was there a 
concurrent decrease in survival time. The authors noted that the historical control data suggested that 
the total 4.4 % incidence of gliomas in all groups of male rats, and the 2.8 % incidence in males and 
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females exposed to Indigo Carmine are within the limits of biological variation. The Panel noted, 
however, that Bernishke et al. (1978) mentioned an incidence of 0.4 % (37/7803) gliomas in controls 
rats (Sprague Dawleys). Therefore, the Panel considered the high incidence of gliomas in males of the 
highest dose group cannot be ignored. 
The Panel noted that statistically significant increased incidences of gliomas and malignant mammary 
gland tumours were seen in the male rats at the highest dose level of 1282 mg Indigo Carmine/kg 
bw/day.  
Overall, the Panel considered that the NOAEL of this study is 632 mg/kg bw/day and 1592 mg/kg 
bw/day for male and female rats, respectively. 
3.2.4.3.  Dogs 
Groups of Beagle dogs (2/sex/group; 1/sex/controls) were given diets containing 1 or 2 % (equivalent 
to  250  or  500 mg/kg  bw/day)  Indigo  Carmine  for  up  to  two  years  (Hansen  et  al.,  1966). 
Histopathological  examinations  were  performed  on  the  following  organs:  heart,  lung,  liver,  gall 
bladder, kidney, spleen, pancreas, adrenal thyroid, mesenteric lymph node, intestine, bone, brain, testis 
and  prostate  or  ovary  and  uterus,  urinary  bladder,  salivary  gland,  sub-maxillary  lymph  node  and 
pituitary. In addition, bone-marrow smears from all dogs were studied. Four out of the six dogs treated 
with 2 % Indigo Carmine died during the two years, and one out of the four treated with 1 % Indigo 
Carmine were sacrificed in a moribund condition. All deaths were attributed to intercurrent virus 
infections. No dye-related clinical signs, gross lesions, or microscopic pathology were noted because 
of deaths from intercurrent virus infections, a no-effect level was not established for Indigo Carmine. 
The Panel noted that due to the design deficiencies and infections no conclusion could be derived from 
this study. 
3.2.5.  Reproductive and developmental toxicity 
3.2.5.1.  Reproductive toxicity studies 
A 2-generation study with continued Indigo Carmine exposure (except during lactation) has been 
conducted in Wistar rats (Oettel et al., 1965). Both the P generation (15 males and 26 females) and the 
F1 generation (20/sex/group; 5/sex/controls) were given diets containing 0 or 1 % Indigo Carmine 
(equivalent to 0 or 500 mg/kg bw/day) for 2 years and observed over their lifespan. No adverse effects 
were  observed  on  fertility,  growth  or  survival.  Reproductive  and  developmental  parameters  were 
poorly reported. The Panel identified a NOAEL of 500 mg/kg bw/day in this study. 
In a 3-generation reproduction study, groups of ten males and twenty female Charles River CD rats 
were fed Indigo Carmine (FD&C Blue No 2
27) at dietary levels providing intakes of 0, 2.5, 25, 75 and 
250 mg/kg bw/day (Borzelleca et al., 1986). Fur and faeces were bluish-coloured in 75 mg/kg bw/day 
and 250 mg/kg bw/day groups. Gestation, viability and lactation indices of all litters from exposed 
animals did not  differ from controls.  Fertility indices were statistically significantly lower for F 2 
female rats in the 2.5 and 25 mg/kg bw/day groups only and consequently considered as not being 
dose-related. Fertility indices were also reduced in F2b and F2c group of male rats. No statistically 
significant changes in the fertility index were observed in the F3 generation. As effects on fertility 
indices in the F2 generation were not dose-related and effects were not identified in the F1 and  F3 
generation this effect was not considered to be compound-related. Examination of the ovaries and uteri 
of F1 dams killed on gestation day (GD) 19 revealed no gross anatomical abnormalities. No unusual 
changes were observed in the stillborn pups or in pups that died during the study. No compound-
related gross or microscopic pathological lesions were noted in any of the F1 or F3a rats that were 
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sacrificed and necropsied. Finally, no compound-related organ-weight variations were recorded in the 
F1 rats. 
According  to  the  authors the  NOAEL for  this  study  was  250 mg  Indigo  Carmine/kg  bw/day,  the 
highest dose tested. The Panel agreed with this NOAEL. 
3.2.5.2.  Developmental toxicity studies 
Rats 
Charles Rivers CD rats (20 pregnant rats/group) received by gavage on GD 6-15 0.5 % methocel 
(controls)  or  Indigo  Carmine  (FD&C  Blue  No  2
28) at doses of 0, 25, 75 or 250  mg/kg bw/day 
(Borzelleca et al., 1987). Indigo Carmine  was  dissolved in 0.5 %  methocel and administered by 
gavage. Animals were observed twice daily during the gestation period for signs of o vert toxicity. 
Body weights were recorded on GD 0, 6, 12, 15 and 20. The animals were killed one day before term. 
No significant compound-related adverse effects were demonstrated on any maternal parameters 
(appearance or behaviour, body weight or mortality) or on any fetal parameters (body weight, viability 
or abnormalities) in rats treated with Indigo Carmine.  
According to the authors the NOAEL of this study is 250  mg Indigo Carmine/kg bw/day, the highest 
dose tested. The Panel agreed with this NOAEL. 
Rabbits 
Pregnant Dutch belted rabbits (10 pregnant does/group) received on GD 6-18 Indigo Carmine (FD&C 
Blue No 2
29) in doses of 0, 25, 75 or 250 mg/kg bw/day by gavage (Borzelleca et al., 1987). Indigo 
Carmine was dissolved in 0.5 % methocel and administered by gavage. Animals were observed twice 
daily during the gestation period for signs of overt toxicity. Body weights were recorded on GD 0, 6, 
13, and 29. The animals were killed 1 day before term. No statistically significant compound-related 
adverse effects were demonstrated on any maternal parameters (appearance or behaviour, body weight 
or mortality) or on any fetal parameters (body weight, viability or abnormalities) in rabbits treated 
with Indigo Carmine.  
According to the authors the NOAEL of this study was 250 mg Indigo Carmine/kg bw/day, the highest 
dose tested. The Panel agreed with this NOAEL. 
3.2.6.  Hypersensitivity, allergenicity and intolerance 
No cases of Indigo Carmine intolerance or allergy have been reported after absorption by the oral 
route. 
4.  Discussion 
The Panel was not provided with a newly submitted dossier and based its evaluation on previous 
evaluations, additional literature that became available since then and the data available following 
EFSA public calls for data. The Panel noted that not all original studies on which previous evaluations 
were based were available for the re-evaluation.  
The Panel noted that the term Indigotin is sometimes used to indicate Indigo while Indigotine is a 
synonym of Indigo Carmine (Regulation (EC) No 1333/2008). In this re-evaluation, only studies with 
Indigo Carmine and Indigotine were taken into consideration, provided that the identity of the test 
material was clear. However, only the term Indigo Carmine is used in this opinion. 
                                                       
28   According to the authors, the test material (FD&C Blue No 2) used in this study was manufactured by the  
  Waner Jenkinson Co. (St. Louis, MO). It was certificated by the FDA prior to its use in this study and it was  
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Indigo Carmine (E 132) is an indigoid colour authorised as a food additive in the EU in accordance 
with Annex II to Regulation (EC) No 1333/2008 which has been previously evaluated by JECFA in 
1969 and 1975 and the SCF in 1975 and 1984. 
JECFA established a temporary ADI of 0-2.5 mg/kg bw/day in 1969 that was increased to a full ADI 
of 0-5 mg/kg bw/day in 1975. These ADIs were probably based on the long-term rat study by Hansen 
et al. (1966) in which a significantly inhibited growth of male rats was observed at dietary doses of 
1000  and  2500 mg/kg  bw/day.  In  this  study,  the  NOAEL  was  determined  to  be  equivalent  to 
500 mg/kg bw/day. JEFCA established a temporary ADI in 1969 probably by applying an uncertainty 
factor of 200 to the above NOAEL. In 1975, JECFA applied an uncertainty factor of 100 to the 
NOAEL of 500 mg/kg bw/day to derive an ADI of 0-5 mg/kg bw/day for Indigo Carmine.  
In 1975 the SCF endorsed an ADI of 0-5 mg/kg bw/day established by JECFA. In the latest evaluation 
of 1984, taking into consideration more recent studies, the SCF agreed to retain this ADI.  
Overall, in vivo studies demonstrated that radioactivity from 
35S-Indigo Carmine was poorly detected 
in urine (1.6 to 2.1 % of the radioactivity) after oral administration in rats. Moreover, incubation of 
35S-Indigo Carmine with intestinal contents of rats for 48 hours suggested that isatin-5-sulphonic acid 
and 5-sulphoanthranilic acid might be metabolites formed by intestinal bacteria. By comparison to the 
data obtained after intravenous administration, the Panel considered that the data available on the 
absorption, metabolism and excretion indicated that Indigo Carmine or its metabolites were poorly 
absorbed.  However,  the  Panel  noted  that  both  identification  of  faecal  metabolites  and  tissue 
distribution of radioactivity were not investigated in these studies. 
Overall, the Panel considered that based on the available data, including a newly performed in vivo 
study on micronuclei induction, Indigo Carmine does not raise concern for genotoxicity. 
In a subacute toxicity study (45-day) performed on adult male Swiss albino mice of B-6 strain (5 
animals/group) at oral doses of 0, 17 and 39 mg Indigo Carmine/kg bw/day, statistically significant 
severe adverse effects on the testis were described (Dixit and Goyal, 2013). The Panel noted that no 
NOAEL could be identified in this study and the LOAEL was 17 mg/kg bw/day, the lowest dose level 
tested.  The  Panel  noted  limitations  in  the  design  of  the  study  and  lack  of  information  on  the 
specifications of the test material used in the study (E 132; FD&C Blue # 2; CI 73015) was procured 
from the local market in India). 
Several chronic toxicity studies were available when JECFA allocated the ADI (1975). Two chronic 
and carcinogenicity studies, one in rats and one in mice were published since the latest evaluation of 
Indigo Carmine by JECFA in 1975.  
In  the  mouse  study,  microscopic  evaluation  of  selected  tissues  revealed  a  variety  of  randomly 
distributed neoplastic, degenerative, hyperplastic and inflammatory changes usually encountered in 
ageing mice (Borzelleca and Hogan, 1985). These changes occurred without relationship to dose and 
are  considered  to  be  unrelated  to  the  dietary  administration  of  Indigo  Carmine.  It  was  therefore 
concluded that this lifetime exposure of mice to Indigo Carmine did not demonstrate carcinogenic or 
toxic effects. The Panel identified a NOAEL in this study equal to 5 % in the diet providing an average 
intake of 8259 mg/kg bw/day for males and 9456 mg/kg bw/day for females.  
In  a  chronic/carcinogenicity  study,  a  statistically  significant  increased  incidence  of  gliomas  and 
malignant mammary gland tumours was seen in the male rats at the highest dose level of 1282 mg 
Indigo Carmine/kg bw/day. Overall, the Panel identified a NOAEL in this study of 632 mg/kg bw/day 
for male rats, the mid-dose, based on these carcinogenic effects. In the absence of any genotoxic 
activity,  the  Panel  considered  that  Indigo  carmine  was  acting  as  a  non-genotoxic  carcinogen  and 
therefore, that there would be a threshold for this effect. Re-evaluation of Indigo Carmine (E 132) as a food additive  
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In a multigeneration reproductive toxicity study no test substance related effects were observed up to 
doses of 250 mg/kg bw/day.  
No adverse effects have been detected in developmental studies in rats and rabbits at tested doses (0, 
25, 75 or 250 mg/kg bw/day). The Panel noted that the concentrations tested in the developmental 
toxicity studies were lower than the dose levels up to 2000 mg/kg bw/day used in several subacute or 
long-term toxicity studies but close to the NOAEL of 500 mg/kg bw/day on which JECFA based its 
ADI.  
No cases of Indigo Carmine intolerance or allergy have been reported after ingestion.  
No  adverse  effects  in  subacute,  chronic,  reproduction  and  developmental toxicity  studies,  and  no 
modifications  of  haematological  and  biological  parameters  in  chronic  toxicity  studies  have  been 
identified at doses less than or equal to 500 mg/kg bw/day. The only report of an adverse effect was in 
testis with a LOAEL of 17 mg/kg bw/day by Dixit and Goya (2013). No such adverse effects have 
been described on testis in long-term toxicity studies in mice and rats (weight of testis, histopathology 
examination) at higher doses. Age-related testicular atrophy of the seminiferous tubules, accompanied 
by  oligospermia  or  aspermia,  was  present  in  male  rats  of  all  groups  in  the  2-year  chronic 
toxicity/carcinogenicity study (Borzelleca et al., 1985) but these lesions were randomly distributed in 
treated and control animals and were not dose-related. The Panel noted also that fertility indices were 
reduced in F2b and F2c group of male rats, but these changes were not considered to be compound-
related because they were not dose-related in the 3-generation reproductive toxicity study (Borcella et 
al, 1986). Overall, the Panel noted that no effects on the testes or reproductive function were observed 
in chronic toxicity studies and in a 3-generation reproduction toxicity study undertaken with Indigo 
Carmine (FD&C Blue No 2) containing approximately 93% pure colouring and 7% volatile matter 
(Borzelleca et al., 1985, 1986,; Borzelleca and Hogan 1985). The Panel considered that the Dixit and 
Goyal (2013) study has shortcomings since it is not clear to the Panel whether the adverse effects 
observed were due to the food additive itself or to impurities and/or contaminants present in the 
material tested and/or to the conduct of the study. 
The Panel considered that the current ADI of 5 mg/kg bw/day was applicable to a material with a 
purity  of  93%  pure  colouring  matter  and  manufactured  using  processes  resulting  in  comparable 
residuals as material used in the Borzelleca et al. studies (1985, 1986) and Borzelleca and Hogan 
(1985). 
Exposure assessment for food additives under re-evaluation was carried out by the ANS Panel based 
on  (1) MPLs  set down in  the  EU legislation  (defined  as  the  regulatory  maximum  level  exposure 
assessment  scenario) and (2)  the  availability  of  adequate  usage  or  analytical data  (defined  as  the 
refined exposure assessment scenario). 
To date, the ANS Panel has used the maximum concentration value (maximum reported use level or 
maximum value from the analytical results) available for each authorised food category. However, 
given the extensive range of analytical data that have been made available through the most recent 
calls, the ANS Panel  considered  this should also be used in  additional scenarios of the exposure 
assessment approach intended to provide more realistic exposure estimates.  
Based on the available dataset, the Panel calculated two estimates based on different assumptions: a 
brand-loyal consumer scenario, where it was assumed that the population is exposed long-term to the 
food additive present at the maximum reported use/analytical levels for one food category; and a non-
brand-loyal scenario,  where it  was assumed that the population is exposed  long-term to the food 
additive present at the mean reported use/analytical levels in the food.  
Overall, the Panel considered the regulatory maximum level exposure assessment scenario as being 
conservative since it assumes that all processed foods and beverages contain the food additive Indigo 
Carmine at the MPLs. The Panel considered that the refined exposure assessment approach was a Re-evaluation of Indigo Carmine (E 132) as a food additive  
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more realistic scenario, since it was based on the extensive range of analytical data and assumes that 
the processed foods and beverages contain the additive at the mean concentration level for all products 
(non-brand-loyal consumer scenario) and considers one product containing  Indigo Carmine at the 
maximum concentration level (brand-loyal consumer scenario). For this exposure assessment scenario, 
food categories for which none or inadequate reported use/analytical levels were available were not 
considered  in  the  exposure  assessment.  Therefore,  the  Panel  noted  that  if  Indigo  Carmine  is 
nevertheless used in those food categories not considered in the exposure estimate, the calculated 
refined exposure assessment might result in underestimation of exposure to Indigo Carmine. The Panel 
also noted that the refined exposure estimates will not cover future changes in the level of use of 
Indigo Carmine. 
Using the regulatory maximum level exposure assessment scenario, mean exposure to Indigo Carmine 
from its use as a food additive ranged from 0.9-3.8 mg/kg bw/day in toddlers, 0.8-3.2 mg/kg bw/day in 
children, 0.3-1.5 mg/kg bw/day in adolescents, 0.3-1.0 mg/kg bw/day in adults and 0.1-0.6 mg/kg 
bw/day in the elderly. The high exposure to Indigo Carmine using this scenario ranged from 2.8-7.1 
mg/kg bw/day in toddlers, 1.8-6.7 mg/kg bw/day in children, 1.0-3.2 mg/kg bw/day in adolescents, 
0.7-2.3  mg/kg  bw/day  in  adults  and  0.5-1.4  mg/kg  bw/day  in  the  elderly.  The  Panel  noted  that 
exposure estimates of Indigo Carmine (E 132) exceed the ADI for toddlers and children at the high 
level (95
th percentile). The main contributing food categories to the total mean exposure estimates for 
adolescents, adults and the elderly in this scenario were flavoured drinks and fine bakery wares. For 
children, the main contributing food categories were flavoured drinks, fine bakery wares and flavoured 
fermented milk products, while for toddlers, the main contributing food categories were flavoured 
fermented milk products and fine bakery wares. 
Using the refined brand-loyal assessment exposure scenario, mean exposure to Indigo Carmine from 
its use as a food additive ranged from 0.02 mg/kg bw/day in adults and the elderly to 0.4 mg/kg 
bw/day in toddlers. The high exposure to Indigo Carmine using this scenario ranged from 0.1 mg/kg 
bw/day in children, adults and the elderly to 0.8 mg/kg bw/day in toddlers and children. The main 
contributing food categories for adolescents, adults and the elderly were flavoured drinks and fine 
bakery wares. For children, the main contributing food categories were fine bakery wares, flavoured 
drinks and other confectionary including breath freshening microsweets. For toddlers, in addition to 
fine  bakery  wares,  flavoured  drinks  and  flavoured  fermented  milk  products  were  also  main 
contributing food categories.  
Using the refined non-brand-loyal assessment exposure scenario, mean exposure to Indigo Carmine 
from its use as a food additive ranged from 0.003 mg/kg bw/day in the elderly to 0.2 mg/kg bw/day in 
toddlers. The high exposure to Indigo Carmine using this scenario ranged from 0.01 mg/kg bw/day in 
the elderly to 0.3 mg/kg bw/day in children. The main contributing food categories for adolescents, 
adults  and  the  elderly  were  also  flavoured  drinks  and  fine  bakery  wares.  For  children,  the  main 
contributing food categories were fine bakery wares and flavoured drinks. For toddlers, fine bakery 
wares and flavoured fermented milk products were the main contributing food categories. 
For  the  refined  exposure  assessment  scenarios  (brand-loyal  and  non-brand-loyal),  none  of  the 
population groups exceeded the ADI of 5 mg/kg bw/day, neither at the mean nor at the high level (95
th 
percentile). However, the Panel noted that this scenario was calculated using limited data provided by 
industry and analytical data made available by EFSA call of data. The Panel further noted that for the 
food categories where both usage levels and analytical results were available, the analytical results 
were much lower than the use levels reported by industry.  
The Panel noted that both reported use levels and quantified analytical results were reported only for 
the food categories of chewing gum, flavoured drinks and desserts. For several food products for 
which the use of Indigo Carmine is authorised e.g. flavoured fermented milk products, seasonings and 
condiments, mustard, soups and broths, sauces, cider and perry, aromatised wine based-products and 
other alcoholic drinks, no usage were reported and also reported analytical data showed only limited 
sample sizes (n<20). In addition, the Panel further noted that for some other authorised food categories Re-evaluation of Indigo Carmine (E 132) as a food additive  
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such as edible ices, fine bakery wares, fish roe, spirit drinks, potato-, cereal, flour-, or starch-based 
snacks and processed nuts, no usages had been reported by industry, while positive analytical results 
(> LOQ) were obtained from the analytical data. 
The Panel noted that the three main contributing food categories for age-groups where MPL scenario 
estimates exceeded the ADI showed high number of analytical data far below MPL or had no use level 
reported combined with no detection in limited analytical data. The Panel therefore considered that it 
is not likely that the ADI will be exceeded. 
CONCLUSIONS  
The Panel noted that no effects on the testes or reproductive function were observed in chronic toxicity 
studies and in a 3-generation reproduction toxicity study undertaken with Indigo Carmine (FD&C 
Blue No 2) containing approximately 93% pure colouring and 7% volatile matter (Borzelleca et al., 
1985, 1986; Borzelleca and Hogan 1985). The EFSA Guidance for submission for food additives 
evaluation requires information on the manufacturing process to identify hazards which may need to 
be controlled in the specifications. The Panel considered that the current ADI of 5 mg/kg bw/day was 
applicable  to  a  material  with  this  purity  manufactured  using  processes  resulting  in  comparable 
residuals. 
The Panel also noted that a new study with Indigo Carmine (E 132; FD&C Blue # 2; CI 73015) 
showing adverse effects on testis (Dixit and Goyal, 2013) would give rise to a safety concern if 
confirmed. The Panel considered that the Dixit and Goyal (2013) study has shortcomings since it is 
not clear to the Panel whether the adverse effects observed were due to the food additive itself or to 
impurities  and/or  contaminants  present  in  the  material  tested  and/or  to  the  conduct  of  the  study. 
However, the Panel noted that the material as described in the publication is presumed to meet the 
current EU specifications and it cannot be excluded that such material could be legally used as a food 
additive in the EU market. Whilst there is no supporting evidence for these effects in the toxicological 
database, the Panel cannot confirm the  applicability of the  existing ADI for all materials (Indigo 
Carmine) meeting the current EU specifications (total colouring matter > 85%).  
The  Panel  concluded  that  any  extension  of  this  ADI  to  Indigo  Carmine  of  lower  purity  and/or 
manufactured using a different process would require new data which would need to address the 
adverse effects on testis observed in the Dixit and Goyal (2013) study. The chemical identity of the 
tested food additive, including the presence of possible impurities and/or contaminants, should be 
investigated and reported.  
The  Panel  confirmed  the  ADI  of  5  mg/kg  bw/day  for  Indigo  Carmine  of  at  least  93%  purity 
manufactured  using  the  same  or  equivalent  manufacturing  process  resulting  in  material  tested  in 
Borzelleca et al. studies. Given the uncertainties in the database, the Panel was not able to conclude 
whether this ADI should apply to Indigo Carmine with lower purity manufactured using these same 
processes or material manufactured using a different but not equivalent process.  
Furthermore, the Panel concluded that the current specifications should be revised in order to restrict 
the Indigo Carmine (E 132) permitted as food additive to that for which the ADI is applicable.  
The  Panel  concluded  that  at  the  maximum  permitted  level  of  use,  exposure  estimates  of  Indigo 
Carmine (E 132) would exceed the ADI for toddlers and children at the high level. Exposure estimates 
using  the  available  usage  and  analytical  data  did  not  show  an  exceedance  of  the  ADI  for  any 
population groups. 
The Panel noted that the three main contributing food categories for age-groups where MPL scenario 
estimates exceeded the ADI showed high number of analytical data far below MPL or had no use level 
reported combined with no detection in limited analytical data. The Panel therefore considered that it 
is not likely that the ADI will be exceeded. Re-evaluation of Indigo Carmine (E 132) as a food additive  
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APPENDICES  
Appendix A.   Summary of reported use levels (mg/kg) of Indigo Carmine (E 132) provided by industry 
FCS 
Category 
No 
FCS 
Food category  MPL  Restrictions/ 
exceptions 
Number 
of data 
 
Reported use levels 
from industry 
Information provided by  Comments  Typical 
mean 
(Range) 
Highest 
maximum 
level  
05.3  Chewing gum  300    1  24  290 
ICGA  
(Only a proportion of 
chewing gum contains this 
food additive and even less 
contains it at the maximum 
reported level.) 
 
05.4 
Decorations, coatings and fillings, 
except fruit based fillings covered 
by category 4.2.4 
500 
only 
decorations, 
coatings and 
sauces, 
except 
fillings 
1  9  9  FDE   
14.1.4  Flavoured drinks  100 
excluding 
chocolate 
milk and malt 
products 
1 NP  20  20  FDE 
As the level is on a niche 
product (NP), the mean 
value used for the 
exposure assessment was 
taken from the analytical 
results from MSs 
16  Desserts excluding products 
covered in category 01, 03 and 04  150    1  20  35  FDE   
17 
Food supplements as defined in 
Directive 2002/46/EC of the 
European Parliament and of the 
Council excluding food 
supplements for infants and 
young children 
    2  45 
(10-80)  280  AESGP   
300    1  0.48  0.96 
Capsugel (data on empty 
capsules, gelatine or HPMC 
based) 
Data considered as not 
relevant for the exposure 
assessment 
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Appendix B.   Summary of analytical results (mg/kg) of Indigo Carmine (E 132) provided by Members States 
FCS 
Category 
No 
FCS food 
category  MPL 
Total 
number  
of data 
Number 
of left-
censored 
data 
      All data  Positive values 
Range  Middle bound  Upper bound  Number  
of positive 
values 
              
LOD  LOQ  min  median  mean  p95  max  min  median  mean  p95  max  min  median  mean  p95  max 
01.4 
Flavoured 
fermented 
milk 
products 
including 
heat treated 
products 
150  10  10  0.17-20  0.5-60  0.3  4.0  3.2  10.0  10.0  0.5  8.0  6.4  20  20                   
1.6.3  Other creams  150  2  1  0.17-0.2  0.5  0.3  0.5  0.5  0.8  0.8  0.5  0.7  0.7  0.8  0.8  1  0.8  0.8  0.8  0.8  0.8 
1.7.1 
Unripened 
cheese 
excluding 
products 
falling in 
category 16 
150  3  3  0.17  0.5-2  0.3  1.0  0.8  1.0  1.0  0.5  2.0  1.5  2  2                   
3  Edible ices  150  136  128  0.04-20  0.1-60  0.1  2.5  2.1  2.5  16.0  0.1  5.0  3.9  5  20  8  0.1  0.3  5.0  16.0  16.0 
5.2 
Other 
confectioner
y including 
breath 
refreshening 
microsweets 
– except 
candied fruit 
and 
vegetables 
300  586  457  0.04-20  0.1-60  0.1  2.5  6.3  10.0  281.0  0.1  3.1  10.0  20  281  129  0.1  1.7  11.6  66.8  281.0 
5.2 
Other 
confectioner
y including 
breath 
refreshening 
microsweets 
– only 
candied fruit 
and 
vegetables 
200  51  51  0.03-20  0.1-60  0.1  0.3  1.9  10.0  10.0  0.1  0.5  3.8  20  20                   
5.3  Chewing 
gum  300  26  20  0.04-20  0.1-60  0.3  1.5  4.3  10.0  10.0  0.3  3.0  8.3  20  20  6  0.3  0.6  1.6  4.5  4.5 Re-evaluation of Indigo Carmine (E 132) as a food additive  
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FCS 
Category 
No 
FCS food 
category  MPL 
Total 
number  
of data 
Number 
of left-
censored 
data 
      All data  Positive values 
Range  Middle bound  Upper bound  Number  
of positive 
values 
              
LOD  LOQ  min  median  mean  p95  max  min  median  mean  p95  max  min  median  mean  p95  max 
5.4 
Decorations, 
coatings and 
fillings, 
except fruit 
based fillings 
covered by 
category 
04.2.4 
500  40  38  0.03-20  0.2-60  0.4  1.5  6.5  18.2  67.7  0.8  3.0  10.6  23.15  67.7  2  26.3  47.0  47.0  67.7  67.7 
6.6  Batters  500  1  1  20  60  10.0  10.0  10.0  10.0  10.0  20.0  20.0  20.0  20  20                   
7.2  Fine bakery 
wares  200  907  892  0.04-20  0.1-60  0.1  10.0  8.9  10.0  34.2  0.1  20.0  17.7  20  34.2  15  0.1  1.5  4.8  34.2  34.2 
9.3  Fish roe  300  6  2  0.04-0.2  0.1-2  0.3  1.0  8.8  48.0  48.0  0.3  1.7  9.1  48  48  4  0.3  1.2  12.7  48.0  48.0 
12.2.2 
Seasonings 
and 
condiments 
500  15  15  3-20  10-60  1.5  10.0  7.8  10.0  10.0  3.0  20.0  15.6  20  20                   
12.4  Mustard  300  6  6  0.17  0.5-5  0.3  2.5  1.8  2.5  2.5  0.5  5.0  3.5  5  5                   
12.5  Soups and 
broths  50  10  10  3-20  10-60  1.5  10.0  9.2  10.0  10.0  3.0  20.0  18.3  20  20                   
12.6  Sauces  500  30  30  3-20  2.75-60  1.4  10.0  8.1  10.0  10.0  2.8  20.0  16.2  20  20                   
14.1.4  Flavoured 
drinks  100  1056  1052  0.04-20  0.1-60  0.0  1.5  3.1  10.0  10.0  0.1  3.0  6.3  20  20  4  0.2  0.3  0.3  0.3  0.3 
14.2.3  Cider and 
perry  200  1  1  3  10  1.5  1.5  1.5  1.5  1.5  3.0  3.0  3.0  3  3                   
14.2.4 
Fruit wine 
and made 
wine 
200  33  33  0.12-20  0.42-60  0.1  1.5  3.8  10.0  10.0  0.1  3.0  7.5  20  20                   
14.2.6 
Spirit drinks 
as defined in 
Regulation 
(EC) No 
110/2008 
200  65  38  0.04-20  0.1-60  0.0  0.3  1.8  10.0  10.0  0.1  0.5  3.4  20  20  27  0.1  0.2  0.6  2.1  4.1 
14.2.7.
2 
Aromatised 
wine-based 
drinks 
200  1  1  20  60  10.0  10.0  10.0  10.0  10.0  20.0  20.0  20.0  20  20                   
14.2.7.
3 
Aromatised 
wine-product 
cocktails 
200  12  12  0.12-20  0.42-60  0.1  1.5  3.7  10.0  10.0  0.1  3.0  7.5  20  20                   
14.2.8 
Other 
alcoholic 
drinks 
including 
mixtures of 
200  19  19  0.06-20  0.14-60  0.0  1.5  2.5  10.0  10.0  0.1  3.0  5.0  20  20                   Re-evaluation of Indigo Carmine (E 132) as a food additive  
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FCS 
Category 
No 
FCS food 
category  MPL 
Total 
number  
of data 
Number 
of left-
censored 
data 
      All data  Positive values 
Range  Middle bound  Upper bound  Number  
of positive 
values 
              
LOD  LOQ  min  median  mean  p95  max  min  median  mean  p95  max  min  median  mean  p95  max 
alcoholic 
drinks with 
non-
alcoholic 
drinks and 
spirits with 
less than 15 
% of alcohol 
15.1 
Potato-, 
cereal-, 
flour- or 
starch-based 
snacks 
100 
25  5  0.04-20  0.1-60  0.1  2.5  8.1  35.0  38.5  0.1  3.0  9.0  34.95  38.5  20  0.1  2.5  9.0  36.7  38.5 
Potato-, 
cereal-, 
flour- or 
starch-based 
snacks 
200 
15.2  Processed 
nuts  100  3  2  0.17-5  0.5-20  0.1  2.5  4.0  9.3  9.3  0.2  5.0  4.8  9.3  9.3  1  9.3  9.3  9.3  9.3  9.3 
16 
Desserts 
excluding 
products 
covered in 
categories 
01, 03  
and 04 
150  39  38  0.8-20  2-60  0.4  10.0  7.8  10.0  10.0  0.8  20.0  15.5  20  20  1  6.1  6.1  6.1  6.1  6.1 
17 
Food 
supplements 
supplied in a 
solid form 
including 
capsules and 
tablets and 
similar forms 
excluding 
chewable 
forms 
300 
36  36  0.17-20  0.5-60  0.3  10.0  6.8  10.0  10.0  0.5  20.0  13.6  20  20 
                 
Food 
supplements 
supplied in a 
liquid form 
100                   Re-evaluation of Indigo Carmine (E 132) as a food additive  
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FCS 
Category 
No 
FCS food 
category  MPL 
Total 
number  
of data 
Number 
of left-
censored 
data 
      All data  Positive values 
Range  Middle bound  Upper bound  Number  
of positive 
values 
              
LOD  LOQ  min  median  mean  p95  max  min  median  mean  p95  max  min  median  mean  p95  max 
Food 
supplements 
supplied in a 
syrup-type or 
chewable 
form 
300                   
Food 
supplements 
supplied in a 
syrup-type or 
chewable 
form 
100                   Re-evaluation of Indigo Carmine (E 132) as a food additive  
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Appendix C.   Concentration levels of  Indigo Carmine (E 132) used in the refined exposure 
scenarios (mg/kg) 
FCS 
Category 
No 
FCS 
Food category  MPL 
Concentration 
levels used in the 
refined exposure 
assessment 
Data source / 
Comments 
mean  max 
01.4  Flavoured fermented milk products  150  3.2  20  Analytical results 
01.6.3  Other creams  150  -  - 
Not taken into account 
(food category too 
broad in FoodEx) 
01.7.1  Unripened cheese excluding 
products falling in category 16  150  0.8  2  Analytical results  
01.7.3  Edible cheese rind  QS  -  - 
Not taken into account 
(no corresponding 
FoodEx code) 
01.7.6  Cheese products (excluding 
products falling in category 16)  100  -  - 
Not taken into account 
(no corresponding 
FoodEx code) 
03  Edible ices  150  2.1  20  Analytical results 
04.2.4.1 
Fruit and vegetable preparations 
excluding compote - only mostarda 
di frutta 
200  -  - 
Not taken into account 
(no corresponding 
FoodEx code) 
05.2 
Other confectionery including 
breath freshening microsweets – 
except candied fruit and vegetables 
300  6.3  281  Analytical results 
05.2 
Other confectionery including 
breath freshening microsweets – 
only candied fruit and vegetables 
200  1.9  20  Analytical results 
05.3  Chewing gum  300  4.3  290  Analytical results/  
Reported use levels 
05.4 
Decorations, coatings and fillings, 
except fruit-based fillings covered 
by category 04.2.4 - only 
decorations, coatings and sauces, 
except fillings 
500  -  - 
Not taken into account 
(no corresponding 
FoodEx code) 
05.4 
Decorations, coatings and fillings, 
except fruit-based fillings covered 
by category 04.2.4 - only fillings 
300  -  - 
Not taken into account 
(no corresponding 
FoodEx code) 
06.6  Batters - only batters for coating  500  -  - 
Not taken into account 
(no corresponding 
FoodEx code) 
07.2  Fine bakery wares  200  8.9  34.2  Analytical results 
08.2.3 
Casings and coatings and 
decorations for meat - only 
decorations and coatings except 
edible external coating of 
pasturmas  
500  -  - 
Not taken into account 
(no corresponding 
FoodEx code) 
08.2.3 
Casings and coatings and 
decorations for meat - only edible 
casings 
QS  -  - 
Not taken into account 
(no corresponding 
FoodEx code) 
09.2 
Processed fish and fishery products 
including molluscs and crustaceans 
- only surimi and similar products 
and salmon substitutes 
500  -  - 
Not taken into account 
(no analytical results or 
reported use levels) 
09.3  Fish roe  300  8.8  48  Analytical results 
12.2.2  Seasonings and condiments  500  7.8  20  Analytical results 
12.4  Mustard  300  1.8  5  Analytical results Re-evaluation of Indigo Carmine (E 132) as a food additive  
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FCS 
Category 
No 
FCS 
Food category  MPL 
Concentration 
levels used in the 
refined exposure 
assessment 
Data source / 
Comments 
mean  max 
12.5  Soups and broths  50  9.2  20  Analytical results 
12.6 
Sauces - including pickles, relishes, 
chutney and piccalilli; excluding 
tomato-based sauces 
500  8.1  20  Analytical results 
12.9 
Protein products, excluding 
products covered in category 01.8 - 
only meat and fish analogues based 
on vegetable proteins 
100  -  - 
Not taken into account 
(no analytical results or 
reported use levels) 
13.2 
Dietary foods for special medical 
purposes defined in Directive 
1999/21/EC (excluding products 
from food category 13.1.5) 
50  -  - 
Not taken into account 
(no analytical results or 
reported use levels) 
13.3 
Dietary foods for weight control 
diets intended to replace total daily 
food intake or an individual meal 
(the whole or part of the total daily 
diet) 
50  -  - 
Not taken into account 
(no analytical results or 
reported use levels) 
14.1.4  Flavoured drinks - excluding 
chocolate milk and malt products  100  3.1  20  Analytical results/ 
Reported use levels 
14.2.3  Cider and perry   200  1.5  3  Analytical results 
14.2.4  Fruit wine and made wine  200  -  - 
Not taken into account 
(no corresponding 
FoodEx code) 
14.2.6  Spirit drinks as defined in 
Regulation (EC) No 110/2008  200  1.8  4.1  Analytical results 
14.2.7  Aromatised wine-based products  200  4.2  20  Analytical results 
14.2.8 
Other alcoholic drinks incl. 
mixtures of alcoholic drinks with 
non-alcoholic drinks and spirits 
with less than 15% of alcohol 
200  2.5  20  Analytical results 
15.1  Potato-, cereal-, flour- or starch-
based snacks  100/200  8.1  38.5  Analytical results 
15.2  Processed nuts  100  4.0  9.3  Analytical results 
16  Desserts  150  20  35  Reported use levels 
17  Food supplements  100/300  45  280  Reported use levels 
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Appendix D.    Summary of total estimated exposure of indigo carmine (E 132) from its use as a 
food additive for MPL scenario and refined exposure scenarios per population group and 
survey: mean and high level (mg/kg bw/day) 
  
Number 
of 
subjects 
MPL scenario  Brand-loyal 
scenario 
Non-brand-loyal 
scenario 
Mean  High 
level  Mean  High 
level  Mean  High 
level 
Toddlers 
Belgium (Regional_Flanders)  36  3.8  -  0.4  -  0.2  - 
Bulgaria (NUTRICHILD)  428  1.1  2.8  0.2  0.4  0.0  0.1 
Germany (DONALD_2006_2008)  261  1.1  3.0  0.1  0.3  0.0  0.1 
Spain (enKid)  17  1.5  -  0.2  -  0.1  - 
Finland (DIPP_2003_2006)  497  0.9  3.1  0.1  0.4  0.0  0.1 
Italy (INRAN_SCAI_2005_06)  36  0.9  -  0.1  -  0.0  - 
Netherlands (VCP_kids)  322  3.3  7.1  0.4  0.8  0.1  0.3 
Children 
Belgium (Regional_Flanders)  625  3.2  6.7  0.3  0.8  0.1  0.3 
Bulgaria (NUTRICHILD)  433  1.4  3.5  0.2  0.5  0.0  0.1 
Czech Republic (SISP04)  389  1.8  4.1  0.2  0.7  0.1  0.1 
Germany (DONALD_2006_2008)  660  1.8  3.9  0.2  0.5  0.1  0.1 
Denmark (Danish_Dietary_Survey)  490  1.5  2.7  0.2  0.5  0.0  0.1 
Spain (enKid)  156  1.5  3.5  0.2  0.5  0.1  0.1 
Spain (NUT_INK05)  399  1.5  3.2  0.1  0.3  0.1  0.1 
Finland (DIPP_2003_2006)  933  1.2  2.9  0.2  0.6  0.0  0.1 
Finland (STRIP)  250  2.4  4.1  0.3  0.7  0.1  0.2 
France (INCA2)  482  1.6  3.1  0.2  0.3  0.1  0.1 
Greece (Regional_Crete)  839  1.0  2.2  0.1  0.3  0.0  0.1 
Italy (INRAN_SCAI_2005_06)  193  0.8  1.8  0.1  0.2  0.0  0.1 
Latvia (EFSA_TEST)  189  1.4  3.3  0.2  0.5  0.1  0.2 
Netherlands (VCP_kids)  957  3.0  6.1  0.3  0.7  0.1  0.3 
Sweden (NFA)  1473  2.8  5.5  0.3  0.7  0.1  0.2 
Adolescents 
Belgium (Diet_National_2004)  584  1.1  2.4  0.1  0.3  0.0  0.1 
Cyprus (Childhealth)  303  0.3  1.0  0.0  0.1  0.0  0.0 
Czech Republic (SISP04)  298  1.3  3.2  0.2  0.5  0.0  0.1 
Germany 
(National_Nutrition_Survey_II)  1011  0.9  2.3  0.1  0.3  0.0  0.1 
Denmark (Danish_Dietary_Survey)  479  1.1  2.4  0.2  0.5  0.0  0.1 
Spain (AESAN_FIAB)  86  0.4  1.0  0.1  0.1  0.0  0.0 
Spain (enKid)  209  1.0  2.3  0.1  0.3  0.0  0.1 
Spain (NUT_INK05)  651  0.8  1.8  0.1  0.2  0.0  0.1 
France (INCA2)  973  0.8  1.7  0.1  0.2  0.0  0.1 
Italy (INRAN_SCAI_2005_06)  247  0.5  1.1  0.0  0.1  0.0  0.0 
Latvia (EFSA_TEST)  470  0.9  2.3  0.1  0.3  0.1  0.1 
Sweden (NFA)  1018  1.5  3.2  0.2  0.5  0.0  0.1 
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Number 
of 
subjects 
MPL scenario  Brand-loyal 
scenario 
Non-brand-loyal 
scenario 
Mean  High 
level  Mean  High 
level  Mean  High 
level 
Belgium (Diet_National_2004)  1304  0.8  2.1  0.1  0.2  0.0  0.1 
Czech Republic (SISP04)  1666  0.5  1.4  0.1  0.2  0.0  0.0 
Germany 
(National_Nutrition_Survey_II)  10419  0.7  1.7  0.1  0.2  0.0  0.1 
Denmark (Danish_Dietary_Survey)  2822  0.5  1.3  0.1  0.2  0.0  0.0 
Spain (AESAN)  410  0.4  1.0  0.0  0.1  0.0  0.0 
Spain (AESAN_FIAB)  981  0.3  0.8  0.0  0.1  0.0  0.0 
Finland (FINDIET_2007)  1575  0.3  1.1  0.1  0.2  0.0  0.0 
France (INCA2)  2276  0.5  1.2  0.0  0.1  0.0  0.0 
United Kingdom (NDNS)  1724  0.7  1.4  0.1  0.1  0.0  0.0 
Hungary (National_Repr_Surv)  1074  0.3  0.8  0.0  0.1  0.0  0.0 
Ireland (NSIFCS)  958  0.5  1.1  0.0  0.1  0.0  0.0 
Italy (INRAN_SCAI_2005_06)  2313  0.3  0.7  0.0  0.1  0.0  0.0 
Latvia (EFSA_TEST)  1306  0.5  1.2  0.1  0.1  0.0  0.1 
Netherlands (DNFCS_2003)  750  1.0  2.3  0.1  0.3  0.0  0.1 
Sweden (Riksmaten_1997_98)  1210  0.6  1.5  0.1  0.2  0.0  0.0 
Elderly and very elderly 
Belgium (Diet_National_2004)  1230  0.6  1.4  0.1  0.2  0.0  0.1 
Germany 
(National_Nutrition_Survey_II)  2496  0.5  1.2  0.1  0.1  0.0  0.1 
Denmark (Danish_Dietary_Survey)  329  0.2  0.7  0.0  0.1  0.0  0.0 
Finland (FINDIET_2007)  463  0.1  0.6  0.0  0.1  0.0  0.0 
France (INCA2)  348  0.4  0.9  0.0  0.1  0.0  0.0 
Hungary (National_Repr_Surv)  286  0.2  0.7  0.0  0.1  0.0  0.0 
Italy (INRAN_SCAI_2005_06)  518  0.2  0.5  0.0  0.1  0.0  0.0 
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GLOSSARY AND ABBREVIATIONS 
ADI  Acceptable daily intake  
AESGP  Association of the European Self-Medication Industry 
Aluminium 
lakes  
Aluminium lakes are produced by the absorption of water soluble dyes onto a 
hydrated aluminium substrate rendering the colour insoluble in water. The end 
product is coloured either by dispersion of the lake into the product or by coating 
onto the surface of the product 
ANS  Scientific Panel on Food Additives and Nutrient Sources added to Food 
bw  Body weight 
CAS  Chemical abstracts service 
DNA  Deoxyribonucleic acid 
EC  European Commission 
EFSA  European Food Safety Authority 
EINECS  European Inventory of Existing Chemical Substances 
EU  European Union 
FAO/WHO  Food and Agriculture Organization/World Health Organization 
FDA  Food and Drug Administration 
FDE  FoodDrinkEurope 
FSC  Food Categorisation System 
GD  Gestation day 
GLP  Good laboratory practices 
HPC/DR  Hepatocyte Primary Culture/DNA Repair  
HPLC  High-performance liquid chromatography 
ICGA  International Chewing Gum Association 
IRMM  Institute for Reference Materials and Measurements 
ISO  International Organization for Standardization. 
IUPAC  International Union of Pure and Applied Chemistry 
JECFA  Joint FAO/WHO Expert Committee on Food Additives  
LC  Liquid chromatography 
LD50  Lethal Dose, 50 % i.e. dose that causes death among 50 % of treated animals 
LOAEL  Lowest observed adverse effect level 
LOD  Limit of detection 
LOQ  Limit of quantification 
MN PCE  Micronucleated polychromatic erythrocytes 
MPL  Maximum Permitted Level 
NDNS  UK National Diet and Nutrition Survey 
NOAEL  No Observed Adverse Effect Level Re-evaluation of Indigo Carmine (E 132) as a food additive  
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NP  Niche products 
OECD  Organisation for Economic Co-operation and Development 
PDA  Diode array detector 
QS  Quantum Satis  
SCE  Sister Chromatid Exchange 
SCF  EU Scientific Committee on Food 
SGOT  Serum glutamic oxaloacetic transaminase  
SGTP  Serum glutamic pyruvic transaminase 
T4  Thyroxine hormone 
tADI  Temporary acceptable daily intake 
TLC  Thin layer chromatography 
TWI  Tolerable Weekly Intake 
UNESDA  Union of European Beverage Associations  
 